This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-196b-5p | A2ML1 | 4.52 | 0 | -0.94 | 0.1549 | MirTarget | -0.16 | 0.02485 | NA | |
2 | hsa-miR-146b-5p | AASS | 2.23 | 0 | -0.79 | 0.00013 | miRanda | -0.26 | 0 | NA | |
3 | hsa-miR-183-5p | ABAT | 2.08 | 0 | -1.27 | 0 | MirTarget | -0.14 | 0.00239 | NA | |
4 | hsa-miR-21-5p | ABAT | 2.22 | 0 | -1.27 | 0 | MirTarget | -0.34 | 5.0E-5 | NA | |
5 | hsa-miR-135b-5p | ABCA1 | 2.8 | 0 | 0.61 | 0.0002 | MirTarget | -0.11 | 0 | NA | |
6 | hsa-miR-183-5p | ABCA1 | 2.08 | 0 | 0.61 | 0.0002 | MirTarget; miRNATAP | -0.17 | 0 | 26935154 | MiR 183 functions as an oncogene by targeting ABCA1 in colon cancer; We found that miR-183 targets the 3'UTR of ABCA1 mRNA; Subsequent experiments confirmed that miR-183 degraded ABCA1 mRNA in the colon cancer cells; Thus we conclude that miR-183 promotes proliferation and inhibits apoptosis by degrading ABCA1 in colon cancer |
7 | hsa-miR-200a-3p | ABCA1 | 2.02 | 0 | 0.61 | 0.0002 | mirMAP | -0.16 | 0 | NA | |
8 | hsa-miR-200b-3p | ABCA1 | 2.06 | 0 | 0.61 | 0.0002 | TargetScan | -0.16 | 0 | NA | |
9 | hsa-miR-200b-3p | ABCA10 | 2.06 | 0 | -0.57 | 0.03674 | mirMAP | -0.28 | 0 | NA | |
10 | hsa-miR-21-5p | ABCA10 | 2.22 | 0 | -0.57 | 0.03674 | mirMAP | -0.34 | 0.00027 | NA | |
11 | hsa-miR-335-3p | ABCA10 | 2.29 | 0 | -0.57 | 0.03674 | mirMAP | -0.3 | 0 | NA | |
12 | hsa-miR-335-3p | ABCA6 | 2.29 | 0 | -1.09 | 0.0003 | mirMAP | -0.48 | 0 | NA | |
13 | hsa-miR-183-5p | ABCA8 | 2.08 | 0 | -2.99 | 0 | MirTarget | -0.87 | 0 | NA | |
14 | hsa-miR-192-5p | ABCA8 | 2.09 | 0 | -2.99 | 0 | miRNAWalker2 validate | -0.49 | 0 | NA | |
15 | hsa-miR-335-3p | ABCA9 | 2.29 | 0 | -1.38 | 0.00017 | mirMAP | -0.53 | 0 | NA | |
16 | hsa-miR-935 | ABCB1 | 2.32 | 0 | -0.7 | 0.00397 | MirTarget | -0.19 | 0 | NA | |
17 | hsa-miR-146b-5p | ABCB5 | 2.23 | 0 | -0.96 | 0.04077 | miRanda | -0.6 | 0 | NA | |
18 | hsa-miR-146b-5p | ABCC5 | 2.23 | 0 | -0.7 | 0 | PITA; miRanda; mirMAP | -0.12 | 0.00125 | NA | |
19 | hsa-miR-335-3p | ABCD2 | 2.29 | 0 | -1.04 | 0.0005 | MirTarget | -0.38 | 0 | NA | |
20 | hsa-miR-146b-5p | ABCG2 | 2.23 | 0 | -1.55 | 0 | miRanda | -0.29 | 0.00035 | NA | |
21 | hsa-miR-183-5p | ABI2 | 2.08 | 0 | 0.18 | 0.14787 | MirTarget | -0.13 | 0 | NA | |
22 | hsa-miR-200b-3p | ABI2 | 2.06 | 0 | 0.18 | 0.14787 | TargetScan | -0.17 | 0 | NA | |
23 | hsa-miR-146b-5p | ABI3BP | 2.23 | 0 | -2.06 | 0 | miRanda | -0.57 | 0 | NA | |
24 | hsa-miR-200a-3p | ABL1 | 2.02 | 0 | -0.21 | 0.07804 | MirTarget | -0.2 | 0 | NA | |
25 | hsa-miR-146b-5p | ABLIM1 | 2.23 | 0 | -0.62 | 0.00019 | mirMAP | -0.11 | 0.0068 | NA | |
26 | hsa-miR-146b-5p | ACADM | 2.23 | 0 | -1.05 | 0 | miRanda | -0.2 | 0 | NA | |
27 | hsa-miR-146b-5p | ACAT1 | 2.23 | 0 | -0.96 | 0 | miRanda | -0.16 | 0 | NA | |
28 | hsa-miR-21-5p | ACAT1 | 2.22 | 0 | -0.96 | 0 | miRNAWalker2 validate | -0.32 | 0 | NA | |
29 | hsa-miR-146b-5p | ACO1 | 2.23 | 0 | -0.75 | 0 | miRanda | -0.15 | 0 | NA | |
30 | hsa-miR-335-3p | ACSBG1 | 2.29 | 0 | -0.89 | 4.0E-5 | mirMAP | -0.29 | 0 | NA | |
31 | hsa-miR-146b-3p | ACSL1 | 2.09 | 0 | -0.58 | 4.0E-5 | PITA | -0.12 | 0.00181 | NA | |
32 | hsa-miR-192-5p | ACSL1 | 2.09 | 0 | -0.58 | 4.0E-5 | miRNAWalker2 validate | -0.11 | 0 | NA | |
33 | hsa-miR-196a-5p | ACSL6 | 5.06 | 0 | -1.59 | 0 | miRNATAP | -0.12 | 0.00101 | NA | |
34 | hsa-miR-196b-5p | ACSL6 | 4.52 | 0 | -1.59 | 0 | miRNATAP | -0.15 | 4.0E-5 | NA | |
35 | hsa-miR-335-3p | ACSL6 | 2.29 | 0 | -1.59 | 0 | MirTarget | -0.28 | 6.0E-5 | NA | |
36 | hsa-miR-935 | ACSL6 | 2.32 | 0 | -1.59 | 0 | PITA | -0.26 | 0 | NA | |
37 | hsa-miR-335-3p | ACSS3 | 2.29 | 0 | -0.4 | 0.15502 | MirTarget; mirMAP | -0.18 | 0.00284 | NA | |
38 | hsa-miR-146b-5p | ACTC1 | 2.23 | 0 | -1.57 | 0.00051 | miRanda | -0.82 | 0 | NA | |
39 | hsa-miR-200b-3p | ACTC1 | 2.06 | 0 | -1.57 | 0.00051 | MirTarget | -0.66 | 0 | NA | |
40 | hsa-miR-200b-3p | ACTR1A | 2.06 | 0 | -0.4 | 0 | TargetScan | -0.11 | 0 | NA | |
41 | hsa-miR-146b-5p | ADAL | 2.23 | 0 | -0.34 | 0.01893 | miRanda | -0.12 | 0.00089 | NA | |
42 | hsa-miR-200a-3p | ADAM22 | 2.02 | 0 | 0.64 | 0.00696 | MirTarget | -0.18 | 1.0E-5 | NA | |
43 | hsa-miR-146b-5p | ADAM23 | 2.23 | 0 | -0.71 | 0.00863 | miRanda | -0.3 | 1.0E-5 | NA | |
44 | hsa-miR-335-3p | ADAMTS17 | 2.29 | 0 | -0.45 | 0.11385 | MirTarget; mirMAP | -0.13 | 0.03944 | NA | |
45 | hsa-miR-200b-3p | ADAMTS3 | 2.06 | 0 | 0.38 | 0.04723 | TargetScan | -0.18 | 0 | NA | |
46 | hsa-miR-194-5p | ADAMTS5 | 2.24 | 0 | 0.19 | 0.27716 | mirMAP | -0.1 | 0.00032 | NA | |
47 | hsa-miR-200b-3p | ADAMTS5 | 2.06 | 0 | 0.19 | 0.27716 | mirMAP | -0.16 | 0 | NA | |
48 | hsa-miR-335-3p | ADAMTS8 | 2.29 | 0 | -1.48 | 0.00069 | MirTarget | -0.71 | 0 | NA | |
49 | hsa-miR-146b-5p | ADAMTSL1 | 2.23 | 0 | -1.98 | 0 | miRanda | -0.42 | 0 | NA | |
50 | hsa-miR-335-3p | ADAMTSL1 | 2.29 | 0 | -1.98 | 0 | mirMAP | -0.45 | 0 | NA | |
51 | hsa-miR-146b-5p | ADARB1 | 2.23 | 0 | -0.34 | 0.06631 | miRanda; mirMAP; miRNATAP | -0.24 | 0 | NA | |
52 | hsa-miR-18a-5p | ADARB1 | 2.05 | 0 | -0.34 | 0.06631 | mirMAP | -0.3 | 0 | NA | |
53 | hsa-miR-192-5p | ADARB1 | 2.09 | 0 | -0.34 | 0.06631 | mirMAP | -0.27 | 0 | NA | |
54 | hsa-miR-200a-3p | ADARB1 | 2.02 | 0 | -0.34 | 0.06631 | MirTarget | -0.32 | 0 | NA | |
55 | hsa-miR-146b-5p | ADCY2 | 2.23 | 0 | -1.53 | 4.0E-5 | miRanda | -0.62 | 0 | NA | |
56 | hsa-miR-192-5p | ADCY2 | 2.09 | 0 | -1.53 | 4.0E-5 | mirMAP | -0.49 | 0 | NA | |
57 | hsa-miR-200b-3p | ADCY2 | 2.06 | 0 | -1.53 | 4.0E-5 | MirTarget; TargetScan | -0.62 | 0 | NA | |
58 | hsa-miR-21-5p | ADCY2 | 2.22 | 0 | -1.53 | 4.0E-5 | MirTarget | -0.78 | 0 | NA | |
59 | hsa-miR-200b-3p | ADCY9 | 2.06 | 0 | -0.36 | 0.01911 | TargetScan | -0.21 | 0 | NA | |
60 | hsa-miR-135b-5p | ADCYAP1 | 2.8 | 0 | -1.7 | 0.00038 | MirTarget | -0.52 | 0 | NA | |
61 | hsa-miR-335-3p | ADCYAP1 | 2.29 | 0 | -1.7 | 0.00038 | mirMAP | -0.59 | 0 | NA | |
62 | hsa-miR-146b-5p | ADD1 | 2.23 | 0 | -0.51 | 0 | miRanda | -0.17 | 0 | NA | |
63 | hsa-miR-200a-5p | ADD2 | 2.19 | 0 | -0.33 | 0.34514 | mirMAP | -0.46 | 0 | NA | |
64 | hsa-miR-146b-5p | ADH5 | 2.23 | 0 | -0.37 | 0.00013 | miRanda | -0.11 | 0 | NA | |
65 | hsa-miR-1-3p | ADPGK | -2.73 | 0 | 0.63 | 0 | MirTarget | -0.12 | 0 | NA | |
66 | hsa-miR-146b-5p | ADRB2 | 2.23 | 0 | -2.78 | 0 | miRanda | -0.49 | 0 | NA | |
67 | hsa-miR-146b-5p | ADRB3 | 2.23 | 0 | -2.9 | 0 | miRanda | -0.89 | 0 | NA | |
68 | hsa-miR-18a-5p | AFAP1 | 2.05 | 0 | 0.34 | 0.01222 | mirMAP | -0.17 | 0 | NA | |
69 | hsa-miR-192-5p | AFAP1 | 2.09 | 0 | 0.34 | 0.01222 | mirMAP | -0.14 | 0 | NA | |
70 | hsa-miR-200a-3p | AFAP1 | 2.02 | 0 | 0.34 | 0.01222 | mirMAP | -0.18 | 0 | NA | |
71 | hsa-miR-146b-5p | AFAP1L2 | 2.23 | 0 | -0.28 | 0.15434 | miRanda; miRNATAP | -0.2 | 5.0E-5 | NA | |
72 | hsa-miR-200b-3p | AFF1 | 2.06 | 0 | -0.38 | 0.00053 | TargetScan | -0.14 | 0 | NA | |
73 | hsa-miR-141-5p | AFF3 | 2.14 | 0 | -2.37 | 0 | mirMAP | -0.66 | 0 | NA | |
74 | hsa-miR-200a-5p | AFF3 | 2.19 | 0 | -2.37 | 0 | MirTarget | -0.56 | 0 | NA | |
75 | hsa-miR-200b-3p | AFF3 | 2.06 | 0 | -2.37 | 0 | MirTarget; TargetScan | -0.56 | 0 | NA | |
76 | hsa-miR-335-3p | AFF3 | 2.29 | 0 | -2.37 | 0 | mirMAP | -0.7 | 0 | NA | |
77 | hsa-miR-18a-5p | AFF4 | 2.05 | 0 | -0.27 | 0.01565 | miRNAWalker2 validate | -0.15 | 0 | NA | |
78 | hsa-miR-146b-3p | AGPAT4 | 2.09 | 0 | 0.09 | 0.61321 | mirMAP | -0.13 | 0.00851 | NA | |
79 | hsa-miR-18a-5p | AGPAT4 | 2.05 | 0 | 0.09 | 0.61321 | mirMAP | -0.21 | 0 | NA | |
80 | hsa-miR-200a-3p | AGPAT4 | 2.02 | 0 | 0.09 | 0.61321 | mirMAP | -0.21 | 0 | NA | |
81 | hsa-miR-335-3p | AGPAT4 | 2.29 | 0 | 0.09 | 0.61321 | mirMAP | -0.18 | 0 | NA | |
82 | hsa-miR-146b-5p | AHNAK | 2.23 | 0 | -1.21 | 0 | miRanda | -0.37 | 0 | NA | |
83 | hsa-miR-200b-3p | AHNAK | 2.06 | 0 | -1.21 | 0 | TargetScan | -0.32 | 0 | NA | |
84 | hsa-miR-335-3p | AICDA | 2.29 | 0 | 0.18 | 0.69918 | mirMAP | -0.21 | 0.04003 | NA | |
85 | hsa-miR-141-5p | AIF1L | 2.14 | 0 | -1.33 | 2.0E-5 | MirTarget | -0.24 | 5.0E-5 | NA | |
86 | hsa-miR-146b-3p | AJAP1 | 2.09 | 0 | -0.56 | 0.04832 | miRNATAP | -0.2 | 0.00594 | NA | |
87 | hsa-miR-183-5p | AJAP1 | 2.08 | 0 | -0.56 | 0.04832 | MirTarget | -0.18 | 0.00064 | NA | |
88 | hsa-miR-200a-3p | AK4 | 2.02 | 0 | -1.12 | 0.00017 | miRNATAP | -0.2 | 3.0E-5 | NA | |
89 | hsa-miR-200b-3p | AK4 | 2.06 | 0 | -1.12 | 0.00017 | mirMAP | -0.24 | 1.0E-5 | NA | |
90 | hsa-miR-335-3p | AK4 | 2.29 | 0 | -1.12 | 0.00017 | mirMAP | -0.23 | 0.00031 | NA | |
91 | hsa-miR-935 | AK4 | 2.32 | 0 | -1.12 | 0.00017 | MirTarget; mirMAP | -0.13 | 0.00371 | NA | |
92 | hsa-miR-135b-5p | AKAP12 | 2.8 | 0 | -0.93 | 0.0028 | mirMAP | -0.34 | 0 | NA | |
93 | hsa-miR-183-5p | AKAP12 | 2.08 | 0 | -0.93 | 0.0028 | miRNAWalker2 validate; miRTarBase | -0.57 | 0 | NA | |
94 | hsa-miR-335-3p | AKAP13 | 2.29 | 0 | 0.03 | 0.7729 | mirMAP | -0.11 | 0 | NA | |
95 | hsa-miR-21-5p | AKAP6 | 2.22 | 0 | -1.59 | 3.0E-5 | MirTarget | -0.92 | 0 | NA | |
96 | hsa-miR-335-3p | AKAP6 | 2.29 | 0 | -1.59 | 3.0E-5 | mirMAP | -0.61 | 0 | NA | |
97 | hsa-miR-92a-1-5p | AKAP6 | 2.05 | 0 | -1.59 | 3.0E-5 | MirTarget | -0.65 | 0 | NA | |
98 | hsa-miR-21-5p | AKIRIN1 | 2.22 | 0 | -0.25 | 0.00144 | miRNATAP | -0.11 | 3.0E-5 | NA | |
99 | hsa-miR-141-5p | AKNAD1 | 2.14 | 0 | -0.46 | 0.00016 | MirTarget | -0.11 | 0 | NA | |
100 | hsa-miR-21-5p | AKT2 | 2.22 | 0 | -0.16 | 0.09338 | miRNAWalker2 validate | -0.13 | 0.00012 | NA | |
101 | hsa-miR-146b-5p | AKT3 | 2.23 | 0 | -0.27 | 0.18865 | miRNAWalker2 validate | -0.26 | 0 | NA | |
102 | hsa-miR-335-3p | AKT3 | 2.29 | 0 | -0.27 | 0.18865 | mirMAP | -0.3 | 0 | NA | |
103 | hsa-miR-335-3p | ALAD | 2.29 | 0 | -0.72 | 0 | mirMAP | -0.15 | 0 | NA | |
104 | hsa-miR-194-5p | ALDH1L2 | 2.24 | 0 | 0.23 | 0.32096 | mirMAP | -0.14 | 0.00018 | NA | |
105 | hsa-miR-335-3p | ALDH1L2 | 2.29 | 0 | 0.23 | 0.32096 | MirTarget | -0.15 | 0.00298 | NA | |
106 | hsa-miR-183-5p | AMIGO2 | 2.08 | 0 | 0.61 | 0.01903 | MirTarget | -0.16 | 0.00083 | NA | |
107 | hsa-miR-192-5p | AMOTL1 | 2.09 | 0 | -0.49 | 0.0546 | mirMAP | -0.44 | 0 | NA | |
108 | hsa-miR-335-3p | AMOTL1 | 2.29 | 0 | -0.49 | 0.0546 | mirMAP | -0.31 | 0 | NA | |
109 | hsa-miR-200b-3p | AMOTL2 | 2.06 | 0 | 0.15 | 0.30776 | MirTarget; TargetScan | -0.11 | 1.0E-5 | NA | |
110 | hsa-miR-146b-5p | AMPH | 2.23 | 0 | -0.92 | 5.0E-5 | PITA; miRanda | -0.35 | 0 | NA | |
111 | hsa-miR-146b-5p | ANGPT1 | 2.23 | 0 | -1.12 | 0 | miRanda | -0.36 | 0 | NA | |
112 | hsa-miR-335-3p | ANGPT1 | 2.29 | 0 | -1.12 | 0 | mirMAP | -0.35 | 0 | NA | |
113 | hsa-miR-146b-5p | ANGPTL1 | 2.23 | 0 | -2.71 | 0 | miRanda | -0.9 | 0 | NA | |
114 | hsa-miR-194-5p | ANGPTL1 | 2.24 | 0 | -2.71 | 0 | MirTarget | -0.77 | 0 | NA | |
115 | hsa-miR-200a-3p | ANGPTL1 | 2.02 | 0 | -2.71 | 0 | MirTarget | -0.91 | 0 | NA | |
116 | hsa-miR-135b-5p | ANGPTL2 | 2.8 | 0 | -0.02 | 0.91748 | MirTarget | -0.19 | 0 | NA | |
117 | hsa-miR-146b-5p | ANGPTL2 | 2.23 | 0 | -0.02 | 0.91748 | miRanda | -0.18 | 0.0018 | NA | |
118 | hsa-miR-335-3p | ANGPTL3 | 2.29 | 0 | -1.68 | 3.0E-5 | mirMAP | -0.29 | 0.00077 | NA | |
119 | hsa-miR-146b-5p | ANK2 | 2.23 | 0 | -1.6 | 1.0E-5 | PITA; miRanda | -0.6 | 0 | NA | |
120 | hsa-miR-200a-3p | ANK2 | 2.02 | 0 | -1.6 | 1.0E-5 | miRNATAP | -0.63 | 0 | NA | |
121 | hsa-miR-335-3p | ANK2 | 2.29 | 0 | -1.6 | 1.0E-5 | mirMAP | -0.57 | 0 | NA | |
122 | hsa-miR-146b-5p | ANKDD1A | 2.23 | 0 | -0.34 | 0.0368 | miRanda | -0.15 | 0.00027 | NA | |
123 | hsa-miR-335-3p | ANKRD12 | 2.29 | 0 | -0.23 | 0.04521 | MirTarget | -0.12 | 0 | NA | |
124 | hsa-miR-335-3p | ANKRD29 | 2.29 | 0 | -1.35 | 1.0E-5 | MirTarget; mirMAP | -0.43 | 0 | NA | |
125 | hsa-miR-135b-5p | ANKRD33B | 2.8 | 0 | -1.03 | 0.00011 | MirTarget | -0.27 | 0 | NA | |
126 | hsa-miR-146b-5p | ANKRD35 | 2.23 | 0 | -1.96 | 0 | miRanda | -0.57 | 0 | NA | |
127 | hsa-miR-183-5p | ANKRD50 | 2.08 | 0 | 0.27 | 0.04034 | MirTarget | -0.11 | 0 | NA | |
128 | hsa-miR-18a-5p | ANKRD50 | 2.05 | 0 | 0.27 | 0.04034 | MirTarget; miRNATAP | -0.15 | 0 | NA | |
129 | hsa-miR-192-5p | ANKRD6 | 2.09 | 0 | -0.36 | 0.03942 | miRNAWalker2 validate | -0.21 | 0 | NA | |
130 | hsa-miR-335-3p | ANKRD6 | 2.29 | 0 | -0.36 | 0.03942 | mirMAP | -0.2 | 0 | NA | |
131 | hsa-miR-146b-5p | ANKS1A | 2.23 | 0 | -0.13 | 0.22949 | mirMAP | -0.18 | 0 | NA | |
132 | hsa-miR-21-5p | ANKS1B | 2.22 | 0 | -0.22 | 0.12837 | MirTarget | -0.17 | 0.00055 | NA | |
133 | hsa-miR-335-3p | ANKS1B | 2.29 | 0 | -0.22 | 0.12837 | mirMAP | -0.11 | 0.00068 | NA | |
134 | hsa-miR-146b-5p | ANO5 | 2.23 | 0 | -2.17 | 0 | miRanda | -0.74 | 0 | NA | |
135 | hsa-miR-200a-3p | ANO5 | 2.02 | 0 | -2.17 | 0 | mirMAP | -0.42 | 0 | NA | |
136 | hsa-miR-200b-3p | ANO5 | 2.06 | 0 | -2.17 | 0 | TargetScan | -0.49 | 0 | NA | |
137 | hsa-miR-192-5p | ANO6 | 2.09 | 0 | -0.09 | 0.50227 | miRNAWalker2 validate | -0.11 | 0 | NA | |
138 | hsa-miR-200a-3p | ANO6 | 2.02 | 0 | -0.09 | 0.50227 | MirTarget | -0.16 | 0 | NA | |
139 | hsa-miR-200b-3p | ANO6 | 2.06 | 0 | -0.09 | 0.50227 | TargetScan | -0.16 | 0 | NA | |
140 | hsa-miR-335-3p | ANTXR1 | 2.29 | 0 | 0.82 | 0.00014 | mirMAP | -0.1 | 0.03103 | NA | |
141 | hsa-miR-335-3p | ANTXR2 | 2.29 | 0 | -0.73 | 0.00186 | MirTarget | -0.32 | 0 | NA | |
142 | hsa-miR-146b-5p | ANXA3 | 2.23 | 0 | -0.5 | 0.0289 | miRanda | -0.13 | 0.02045 | NA | |
143 | hsa-miR-1-3p | ANXA4 | -2.73 | 0 | 0.62 | 0.00058 | MirTarget | -0.14 | 0 | NA | |
144 | hsa-miR-146b-5p | AOC3 | 2.23 | 0 | -1.42 | 1.0E-5 | miRanda | -0.57 | 0 | NA | |
145 | hsa-miR-335-3p | AOX1 | 2.29 | 0 | -1.37 | 0.00036 | mirMAP | -0.41 | 0 | NA | |
146 | hsa-miR-1-3p | AP1S1 | -2.73 | 0 | 0.36 | 0.02361 | MirTarget | -0.12 | 0 | NA | |
147 | hsa-miR-141-5p | AP1S2 | 2.14 | 0 | -0.61 | 0.00205 | MirTarget | -0.43 | 0 | NA | |
148 | hsa-miR-192-5p | AP1S2 | 2.09 | 0 | -0.61 | 0.00205 | miRNAWalker2 validate | -0.34 | 0 | NA | |
149 | hsa-miR-200b-3p | AP1S2 | 2.06 | 0 | -0.61 | 0.00205 | MirTarget; TargetScan | -0.41 | 0 | NA | |
150 | hsa-miR-335-3p | AP1S2 | 2.29 | 0 | -0.61 | 0.00205 | mirMAP | -0.29 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEUROGENESIS | 362 | 1402 | 1.383e-51 | 6.437e-48 |
2 | CELL DEVELOPMENT | 347 | 1426 | 4.183e-43 | 9.731e-40 |
3 | REGULATION OF CELL DIFFERENTIATION | 345 | 1492 | 8.357e-38 | 1.296e-34 |
4 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 373 | 1672 | 2.288e-37 | 2.661e-34 |
5 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 167 | 513 | 1.432e-36 | 1.333e-33 |
6 | REGULATION OF CELL DEVELOPMENT | 226 | 836 | 5.051e-35 | 3.917e-32 |
7 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 210 | 750 | 6.36e-35 | 4.228e-32 |
8 | CELLULAR COMPONENT MORPHOGENESIS | 235 | 900 | 7.227e-34 | 4.203e-31 |
9 | NEURON DIFFERENTIATION | 229 | 874 | 3.035e-33 | 1.569e-30 |
10 | REGULATION OF NEURON DIFFERENTIATION | 169 | 554 | 4.536e-33 | 2.111e-30 |
11 | NEURON PROJECTION DEVELOPMENT | 165 | 545 | 7.243e-32 | 3.064e-29 |
12 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 208 | 788 | 1.106e-30 | 3.96e-28 |
13 | CIRCULATORY SYSTEM DEVELOPMENT | 208 | 788 | 1.106e-30 | 3.96e-28 |
14 | NEURON DEVELOPMENT | 189 | 687 | 2.219e-30 | 7.376e-28 |
15 | NEURON PROJECTION MORPHOGENESIS | 133 | 402 | 4.524e-30 | 1.403e-27 |
16 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 124 | 368 | 6.011e-29 | 1.748e-26 |
17 | CELL PROJECTION ORGANIZATION | 224 | 902 | 6.668e-29 | 1.825e-26 |
18 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 264 | 1142 | 1.058e-28 | 2.735e-26 |
19 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 285 | 1275 | 1.989e-28 | 4.872e-26 |
20 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 216 | 872 | 1.021e-27 | 2.374e-25 |
21 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 128 | 408 | 1.64e-26 | 3.633e-24 |
22 | LOCOMOTION | 253 | 1114 | 2.762e-26 | 5.841e-24 |
23 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 236 | 1021 | 1.193e-25 | 2.413e-23 |
24 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 193 | 771 | 2.086e-25 | 3.883e-23 |
25 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 202 | 823 | 2.082e-25 | 3.883e-23 |
26 | BEHAVIOR | 146 | 516 | 5.828e-25 | 1.043e-22 |
27 | CELL PART MORPHOGENESIS | 167 | 633 | 1.022e-24 | 1.761e-22 |
28 | TISSUE DEVELOPMENT | 310 | 1518 | 6.476e-24 | 1.076e-21 |
29 | REGULATION OF CELL PROJECTION ORGANIZATION | 151 | 558 | 1.264e-23 | 1.96e-21 |
30 | HEAD DEVELOPMENT | 178 | 709 | 1.231e-23 | 1.96e-21 |
31 | SINGLE ORGANISM BEHAVIOR | 117 | 384 | 3.974e-23 | 5.964e-21 |
32 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 288 | 1395 | 5.989e-23 | 8.708e-21 |
33 | REGULATION OF SYSTEM PROCESS | 140 | 507 | 7.157e-23 | 1.009e-20 |
34 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 126 | 437 | 1.833e-22 | 2.508e-20 |
35 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 100 | 306 | 1.963e-22 | 2.609e-20 |
36 | RESPONSE TO ENDOGENOUS STIMULUS | 294 | 1450 | 3.592e-22 | 4.643e-20 |
37 | POSITIVE REGULATION OF CELL DEVELOPMENT | 128 | 472 | 2.866e-20 | 3.604e-18 |
38 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 185 | 801 | 3.51e-20 | 4.298e-18 |
39 | CELL MOTILITY | 189 | 835 | 1.393e-19 | 1.543e-17 |
40 | LOCALIZATION OF CELL | 189 | 835 | 1.393e-19 | 1.543e-17 |
41 | VASCULATURE DEVELOPMENT | 126 | 469 | 1.336e-19 | 1.543e-17 |
42 | REGULATION OF TRANSPORT | 338 | 1804 | 1.381e-19 | 1.543e-17 |
43 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 79 | 232 | 3.353e-19 | 3.628e-17 |
44 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 215 | 1008 | 6.446e-19 | 6.816e-17 |
45 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 93 | 303 | 7.13e-19 | 7.372e-17 |
46 | REGULATION OF CELL MORPHOGENESIS | 139 | 552 | 8.737e-19 | 8.838e-17 |
47 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 210 | 983 | 1.418e-18 | 1.404e-16 |
48 | MODULATION OF SYNAPTIC TRANSMISSION | 92 | 301 | 1.498e-18 | 1.453e-16 |
49 | HEART DEVELOPMENT | 123 | 466 | 1.724e-18 | 1.637e-16 |
50 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 329 | 1784 | 5.563e-18 | 5.177e-16 |
51 | ORGAN MORPHOGENESIS | 185 | 841 | 8.157e-18 | 7.442e-16 |
52 | REGULATION OF DEVELOPMENTAL GROWTH | 88 | 289 | 1.095e-17 | 9.796e-16 |
53 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 203 | 957 | 1.261e-17 | 1.107e-15 |
54 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 97 | 337 | 1.615e-17 | 1.367e-15 |
55 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 303 | 1618 | 1.609e-17 | 1.367e-15 |
56 | COGNITION | 80 | 251 | 1.74e-17 | 1.446e-15 |
57 | BIOLOGICAL ADHESION | 213 | 1032 | 4.675e-17 | 3.816e-15 |
58 | NEURON PROJECTION GUIDANCE | 69 | 205 | 1.206e-16 | 9.677e-15 |
59 | BLOOD VESSEL MORPHOGENESIS | 100 | 364 | 1.637e-16 | 1.291e-14 |
60 | REGULATION OF MEMBRANE POTENTIAL | 96 | 343 | 1.786e-16 | 1.385e-14 |
61 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 119 | 472 | 2.718e-16 | 2.073e-14 |
62 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 88 | 303 | 2.814e-16 | 2.112e-14 |
63 | MESENCHYME DEVELOPMENT | 65 | 190 | 3.705e-16 | 2.737e-14 |
64 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 142 | 609 | 4.391e-16 | 3.192e-14 |
65 | REGULATION OF BLOOD CIRCULATION | 86 | 295 | 4.795e-16 | 3.432e-14 |
66 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 210 | 1036 | 6.072e-16 | 4.217e-14 |
67 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 210 | 1036 | 6.072e-16 | 4.217e-14 |
68 | MUSCLE STRUCTURE DEVELOPMENT | 111 | 432 | 6.66e-16 | 4.558e-14 |
69 | MESENCHYMAL CELL DIFFERENTIATION | 52 | 134 | 8.527e-16 | 5.75e-14 |
70 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 88 | 312 | 1.969e-15 | 1.309e-13 |
71 | REGULATION OF HEART CONTRACTION | 70 | 221 | 2.566e-15 | 1.682e-13 |
72 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 153 | 689 | 2.836e-15 | 1.833e-13 |
73 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 78 | 262 | 3.134e-15 | 1.998e-13 |
74 | STEM CELL DIFFERENTIATION | 63 | 190 | 5.704e-15 | 3.586e-13 |
75 | REGULATION OF AXONOGENESIS | 58 | 168 | 9.045e-15 | 5.611e-13 |
76 | POSITIVE REGULATION OF LOCOMOTION | 106 | 420 | 1.106e-14 | 6.77e-13 |
77 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 223 | 1152 | 1.364e-14 | 8.243e-13 |
78 | RESPONSE TO HORMONE | 183 | 893 | 1.805e-14 | 1.077e-12 |
79 | TAXIS | 113 | 464 | 2.087e-14 | 1.229e-12 |
80 | REGULATION OF CELLULAR COMPONENT SIZE | 90 | 337 | 3.379e-14 | 1.965e-12 |
81 | REGULATION OF ION TRANSPORT | 134 | 592 | 3.484e-14 | 2.002e-12 |
82 | SYNAPSE ORGANIZATION | 52 | 145 | 3.768e-14 | 2.138e-12 |
83 | SYNAPTIC SIGNALING | 105 | 424 | 5.591e-14 | 3.134e-12 |
84 | TUBE DEVELOPMENT | 126 | 552 | 1.092e-13 | 6.046e-12 |
85 | REGULATION OF EXTENT OF CELL GROWTH | 41 | 101 | 1.573e-13 | 8.613e-12 |
86 | MUSCLE TISSUE DEVELOPMENT | 77 | 275 | 1.71e-13 | 9.252e-12 |
87 | FOREBRAIN DEVELOPMENT | 92 | 357 | 1.737e-13 | 9.291e-12 |
88 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 160 | 767 | 1.883e-13 | 9.954e-12 |
89 | NEURON MIGRATION | 43 | 110 | 1.938e-13 | 1.013e-11 |
90 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 292 | 1656 | 1.975e-13 | 1.021e-11 |
91 | REGULATION OF CELL PROLIFERATION | 269 | 1496 | 2.063e-13 | 1.055e-11 |
92 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 196 | 1004 | 2.736e-13 | 1.384e-11 |
93 | RESPONSE TO GROWTH FACTOR | 112 | 475 | 2.768e-13 | 1.385e-11 |
94 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 318 | 1848 | 3.568e-13 | 1.766e-11 |
95 | CELL CELL SIGNALING | 159 | 767 | 3.868e-13 | 1.894e-11 |
96 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 68 | 232 | 4.228e-13 | 2.049e-11 |
97 | POSITIVE REGULATION OF CELL PROLIFERATION | 166 | 814 | 4.912e-13 | 2.356e-11 |
98 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 308 | 1791 | 9.716e-13 | 4.613e-11 |
99 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 59 | 191 | 1.302e-12 | 6.054e-11 |
100 | ACTIN FILAMENT BASED PROCESS | 106 | 450 | 1.296e-12 | 6.054e-11 |
101 | REGULATION OF PROTEIN MODIFICATION PROCESS | 296 | 1710 | 1.314e-12 | 6.054e-11 |
102 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 249 | 1381 | 1.349e-12 | 6.155e-11 |
103 | POSITIVE REGULATION OF GENE EXPRESSION | 299 | 1733 | 1.484e-12 | 6.706e-11 |
104 | INTRACELLULAR SIGNAL TRANSDUCTION | 276 | 1572 | 1.658e-12 | 7.42e-11 |
105 | CIRCULATORY SYSTEM PROCESS | 91 | 366 | 2.13e-12 | 9.437e-11 |
106 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 308 | 1805 | 2.57e-12 | 1.128e-10 |
107 | TISSUE MORPHOGENESIS | 119 | 533 | 2.598e-12 | 1.13e-10 |
108 | NEGATIVE REGULATION OF CELL COMMUNICATION | 220 | 1192 | 3.127e-12 | 1.347e-10 |
109 | REGULATION OF NEUROTRANSMITTER LEVELS | 58 | 190 | 3.487e-12 | 1.489e-10 |
110 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 53 | 166 | 4.297e-12 | 1.818e-10 |
111 | REGULATION OF CELL SIZE | 54 | 172 | 5.685e-12 | 2.383e-10 |
112 | ANGIOGENESIS | 77 | 293 | 5.754e-12 | 2.391e-10 |
113 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 243 | 1360 | 6.827e-12 | 2.811e-10 |
114 | POSITIVE REGULATION OF CELL COMMUNICATION | 267 | 1532 | 9.211e-12 | 3.76e-10 |
115 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 150 | 740 | 1.109e-11 | 4.488e-10 |
116 | EPITHELIUM DEVELOPMENT | 181 | 945 | 1.297e-11 | 5.203e-10 |
117 | MUSCLE SYSTEM PROCESS | 74 | 282 | 1.602e-11 | 6.372e-10 |
118 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 34 | 84 | 2.023e-11 | 7.978e-10 |
119 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 176 | 917 | 2.124e-11 | 8.306e-10 |
120 | REGULATION OF GTPASE ACTIVITY | 138 | 673 | 3.293e-11 | 1.277e-09 |
121 | SKELETAL SYSTEM DEVELOPMENT | 103 | 455 | 3.348e-11 | 1.287e-09 |
122 | REGULATION OF CELLULAR LOCALIZATION | 228 | 1277 | 3.52e-11 | 1.316e-09 |
123 | ACTION POTENTIAL | 36 | 94 | 3.519e-11 | 1.316e-09 |
124 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 110 | 498 | 3.536e-11 | 1.316e-09 |
125 | MUSCLE CELL DIFFERENTIATION | 65 | 237 | 3.51e-11 | 1.316e-09 |
126 | REGULATION OF TRANSMEMBRANE TRANSPORT | 98 | 426 | 3.873e-11 | 1.43e-09 |
127 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 157 | 799 | 4.399e-11 | 1.612e-09 |
128 | TELENCEPHALON DEVELOPMENT | 63 | 228 | 4.973e-11 | 1.808e-09 |
129 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 49 | 156 | 5.276e-11 | 1.903e-09 |
130 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 30 | 70 | 5.525e-11 | 1.978e-09 |
131 | REGULATION OF METAL ION TRANSPORT | 80 | 325 | 7.764e-11 | 2.758e-09 |
132 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 45 | 138 | 7.939e-11 | 2.798e-09 |
133 | NEURAL CREST CELL DIFFERENTIATION | 31 | 75 | 8.162e-11 | 2.855e-09 |
134 | REGULATION OF DENDRITE DEVELOPMENT | 41 | 120 | 1.064e-10 | 3.695e-09 |
135 | AMEBOIDAL TYPE CELL MIGRATION | 48 | 154 | 1.117e-10 | 3.821e-09 |
136 | REGULATION OF GROWTH | 130 | 633 | 1.117e-10 | 3.821e-09 |
137 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 260 | 1518 | 1.133e-10 | 3.848e-09 |
138 | REGULATION OF MUSCLE SYSTEM PROCESS | 56 | 195 | 1.163e-10 | 3.922e-09 |
139 | CELLULAR RESPONSE TO HORMONE STIMULUS | 117 | 552 | 1.302e-10 | 4.358e-09 |
140 | TUBE MORPHOGENESIS | 79 | 323 | 1.419e-10 | 4.716e-09 |
141 | RESPONSE TO NITROGEN COMPOUND | 164 | 859 | 1.616e-10 | 5.333e-09 |
142 | REGULATION OF MAPK CASCADE | 133 | 660 | 2.551e-10 | 8.299e-09 |
143 | MULTICELLULAR ORGANISMAL SIGNALING | 41 | 123 | 2.539e-10 | 8.299e-09 |
144 | GROWTH | 93 | 410 | 2.704e-10 | 8.677e-09 |
145 | REGULATION OF OSSIFICATION | 52 | 178 | 2.695e-10 | 8.677e-09 |
146 | DEVELOPMENTAL GROWTH | 80 | 333 | 2.742e-10 | 8.738e-09 |
147 | UROGENITAL SYSTEM DEVELOPMENT | 74 | 299 | 3.041e-10 | 9.626e-09 |
148 | MORPHOGENESIS OF AN EPITHELIUM | 91 | 400 | 3.577e-10 | 1.125e-08 |
149 | GLIOGENESIS | 51 | 175 | 4.386e-10 | 1.37e-08 |
150 | ADULT BEHAVIOR | 43 | 135 | 4.798e-10 | 1.488e-08 |
151 | REGULATION OF EPITHELIAL CELL MIGRATION | 49 | 166 | 5.912e-10 | 1.822e-08 |
152 | EMBRYO DEVELOPMENT | 167 | 894 | 6.083e-10 | 1.862e-08 |
153 | MEMORY | 35 | 98 | 6.183e-10 | 1.88e-08 |
154 | REGULATION OF CELL DEATH | 250 | 1472 | 6.245e-10 | 1.887e-08 |
155 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 202 | 1135 | 6.737e-10 | 2.022e-08 |
156 | HINDBRAIN DEVELOPMENT | 43 | 137 | 8.047e-10 | 2.4e-08 |
157 | CONNECTIVE TISSUE DEVELOPMENT | 54 | 194 | 8.751e-10 | 2.594e-08 |
158 | LOCOMOTORY BEHAVIOR | 51 | 181 | 1.607e-09 | 4.733e-08 |
159 | LEARNING | 41 | 131 | 2.173e-09 | 6.36e-08 |
160 | PROTEIN PHOSPHORYLATION | 172 | 944 | 2.327e-09 | 6.766e-08 |
161 | REGULATION OF KINASE ACTIVITY | 147 | 776 | 2.579e-09 | 7.453e-08 |
162 | CARTILAGE DEVELOPMENT | 44 | 147 | 2.719e-09 | 7.808e-08 |
163 | STRIATED MUSCLE CELL DIFFERENTIATION | 49 | 173 | 2.759e-09 | 7.875e-08 |
164 | REGULATION OF SYNAPSE ORGANIZATION | 37 | 113 | 3.274e-09 | 9.288e-08 |
165 | PALLIUM DEVELOPMENT | 45 | 153 | 3.327e-09 | 9.383e-08 |
166 | NEGATIVE REGULATION OF LOCOMOTION | 65 | 263 | 3.827e-09 | 1.073e-07 |
167 | NEGATIVE REGULATION OF GENE EXPRESSION | 249 | 1493 | 3.871e-09 | 1.079e-07 |
168 | EMBRYONIC MORPHOGENESIS | 110 | 539 | 4.458e-09 | 1.227e-07 |
169 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 43 | 144 | 4.443e-09 | 1.227e-07 |
170 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 19 | 37 | 4.56e-09 | 1.248e-07 |
171 | POSITIVE REGULATION OF MAPK CASCADE | 99 | 470 | 4.894e-09 | 1.332e-07 |
172 | CARDIAC CONDUCTION | 30 | 82 | 5.315e-09 | 1.438e-07 |
173 | RESPONSE TO STEROID HORMONE | 103 | 497 | 5.954e-09 | 1.601e-07 |
174 | REGULATION OF CELL GROWTH | 86 | 391 | 6.067e-09 | 1.622e-07 |
175 | RESPONSE TO LIPID | 162 | 888 | 6.342e-09 | 1.686e-07 |
176 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 251 | 1517 | 7.01e-09 | 1.853e-07 |
177 | SECRETION BY CELL | 101 | 486 | 7.189e-09 | 1.89e-07 |
178 | GLIAL CELL DIFFERENTIATION | 41 | 136 | 7.42e-09 | 1.94e-07 |
179 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 68 | 285 | 7.939e-09 | 2.056e-07 |
180 | REGULATION OF CELL ADHESION | 123 | 629 | 7.955e-09 | 2.056e-07 |
181 | REGULATION OF CELL SUBSTRATE ADHESION | 48 | 173 | 8.313e-09 | 2.137e-07 |
182 | NEGATIVE REGULATION OF CELL PROLIFERATION | 125 | 643 | 8.633e-09 | 2.207e-07 |
183 | AMINOGLYCAN BIOSYNTHETIC PROCESS | 35 | 107 | 8.895e-09 | 2.262e-07 |
184 | NEGATIVE REGULATION OF CELL DEATH | 159 | 872 | 9.132e-09 | 2.309e-07 |
185 | CYTOSKELETON ORGANIZATION | 154 | 838 | 9.2e-09 | 2.314e-07 |
186 | POSITIVE REGULATION OF KINASE ACTIVITY | 100 | 482 | 9.345e-09 | 2.338e-07 |
187 | DENDRITE MORPHOGENESIS | 20 | 42 | 9.648e-09 | 2.401e-07 |
188 | FOREBRAIN CELL MIGRATION | 25 | 62 | 9.979e-09 | 2.47e-07 |
189 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 58 | 229 | 1.006e-08 | 2.477e-07 |
190 | POSITIVE REGULATION OF OSSIFICATION | 30 | 84 | 1.021e-08 | 2.499e-07 |
191 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 54 | 208 | 1.287e-08 | 3.135e-07 |
192 | CELL CELL ADHESION | 119 | 608 | 1.324e-08 | 3.208e-07 |
193 | MUSCLE ORGAN DEVELOPMENT | 66 | 277 | 1.39e-08 | 3.35e-07 |
194 | NEGATIVE CHEMOTAXIS | 19 | 39 | 1.407e-08 | 3.374e-07 |
195 | SECOND MESSENGER MEDIATED SIGNALING | 45 | 160 | 1.53e-08 | 3.652e-07 |
196 | NEUROTRANSMITTER TRANSPORT | 44 | 155 | 1.624e-08 | 3.855e-07 |
197 | NEURAL CREST CELL MIGRATION | 22 | 51 | 1.737e-08 | 4.104e-07 |
198 | POSITIVE REGULATION OF GROWTH | 59 | 238 | 1.756e-08 | 4.126e-07 |
199 | REGULATION OF SYNAPTIC PLASTICITY | 41 | 140 | 1.872e-08 | 4.378e-07 |
200 | RESPONSE TO EXTERNAL STIMULUS | 290 | 1821 | 2.07e-08 | 4.815e-07 |
201 | ENSHEATHMENT OF NEURONS | 31 | 91 | 2.113e-08 | 4.868e-07 |
202 | AXON ENSHEATHMENT | 31 | 91 | 2.113e-08 | 4.868e-07 |
203 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 46 | 167 | 2.156e-08 | 4.941e-07 |
204 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 162 | 905 | 2.429e-08 | 5.54e-07 |
205 | POSITIVE REGULATION OF AXONOGENESIS | 26 | 69 | 2.711e-08 | 6.152e-07 |
206 | SENSORY ORGAN DEVELOPMENT | 100 | 493 | 3.096e-08 | 6.992e-07 |
207 | NEGATIVE REGULATION OF GROWTH | 58 | 236 | 3.219e-08 | 7.237e-07 |
208 | DENDRITE DEVELOPMENT | 28 | 79 | 3.798e-08 | 8.454e-07 |
209 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 303 | 1929 | 3.816e-08 | 8.454e-07 |
210 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 86 | 406 | 3.803e-08 | 8.454e-07 |
211 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 33 | 103 | 4.145e-08 | 9.141e-07 |
212 | RESPONSE TO ABIOTIC STIMULUS | 178 | 1024 | 4.263e-08 | 9.355e-07 |
213 | SYSTEM PROCESS | 283 | 1785 | 4.815e-08 | 1.052e-06 |
214 | RESPONSE TO MECHANICAL STIMULUS | 53 | 210 | 4.865e-08 | 1.058e-06 |
215 | CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 15 | 27 | 4.904e-08 | 1.061e-06 |
216 | MUSCLE CONTRACTION | 57 | 233 | 5.006e-08 | 1.078e-06 |
217 | NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 24 | 62 | 5.029e-08 | 1.078e-06 |
218 | EXOCYTOSIS | 70 | 310 | 5.196e-08 | 1.109e-06 |
219 | REGULATION OF HYDROLASE ACTIVITY | 220 | 1327 | 5.566e-08 | 1.183e-06 |
220 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 40 | 140 | 5.9e-08 | 1.248e-06 |
221 | RESPONSE TO OXYGEN LEVELS | 70 | 311 | 5.945e-08 | 1.252e-06 |
222 | BONE DEVELOPMENT | 43 | 156 | 6.007e-08 | 1.259e-06 |
223 | CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 20 | 46 | 6.586e-08 | 1.374e-06 |
224 | HEART MORPHOGENESIS | 53 | 212 | 6.814e-08 | 1.409e-06 |
225 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 44 | 162 | 6.787e-08 | 1.409e-06 |
226 | POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 34 | 110 | 7.028e-08 | 1.447e-06 |
227 | EMBRYONIC ORGAN DEVELOPMENT | 85 | 406 | 7.872e-08 | 1.613e-06 |
228 | REGULATION OF MUSCLE CONTRACTION | 41 | 147 | 8.469e-08 | 1.728e-06 |
229 | CARDIOCYTE DIFFERENTIATION | 31 | 96 | 8.63e-08 | 1.753e-06 |
230 | POSITIVE REGULATION OF TRANSPORT | 164 | 936 | 8.701e-08 | 1.76e-06 |
231 | REGULATION OF CHEMOTAXIS | 47 | 180 | 9.134e-08 | 1.84e-06 |
232 | RESPIRATORY SYSTEM DEVELOPMENT | 50 | 197 | 9.527e-08 | 1.911e-06 |
233 | SINGLE ORGANISM CELL ADHESION | 93 | 459 | 9.883e-08 | 1.97e-06 |
234 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 54 | 220 | 9.907e-08 | 1.97e-06 |
235 | CELL SUBSTRATE ADHESION | 44 | 164 | 1e-07 | 1.98e-06 |
236 | POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 24 | 64 | 1.027e-07 | 2.024e-06 |
237 | REGULATION OF CALCIUM ION TRANSPORT | 52 | 209 | 1.066e-07 | 2.092e-06 |
238 | REGULATION OF HOMEOSTATIC PROCESS | 91 | 447 | 1.08e-07 | 2.111e-06 |
239 | REGULATION OF TRANSPORTER ACTIVITY | 50 | 198 | 1.131e-07 | 2.201e-06 |
240 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 241 | 1492 | 1.158e-07 | 2.245e-06 |
241 | CARDIAC MUSCLE CELL DIFFERENTIATION | 26 | 74 | 1.411e-07 | 2.725e-06 |
242 | SECRETION | 112 | 588 | 1.558e-07 | 2.995e-06 |
243 | CELLULAR RESPONSE TO LIPID | 92 | 457 | 1.574e-07 | 3.001e-06 |
244 | REGULATION OF SYNAPSE ASSEMBLY | 27 | 79 | 1.569e-07 | 3.001e-06 |
245 | RESPONSE TO ALCOHOL | 77 | 362 | 1.62e-07 | 3.077e-06 |
246 | CARDIAC MUSCLE CELL CONTRACTION | 15 | 29 | 1.736e-07 | 3.284e-06 |
247 | EAR DEVELOPMENT | 49 | 195 | 1.774e-07 | 3.343e-06 |
248 | RESPONSE TO WOUNDING | 108 | 563 | 1.797e-07 | 3.372e-06 |
249 | REGULATED EXOCYTOSIS | 54 | 224 | 1.864e-07 | 3.483e-06 |
250 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 32 | 104 | 1.898e-07 | 3.532e-06 |
251 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 99 | 505 | 2.029e-07 | 3.761e-06 |
252 | KIDNEY EPITHELIUM DEVELOPMENT | 36 | 125 | 2.141e-07 | 3.953e-06 |
253 | HEART PROCESS | 28 | 85 | 2.247e-07 | 4.133e-06 |
254 | NEPHRON DEVELOPMENT | 34 | 115 | 2.321e-07 | 4.252e-06 |
255 | AXON EXTENSION | 17 | 37 | 2.401e-07 | 4.364e-06 |
256 | CAMP MEDIATED SIGNALING | 17 | 37 | 2.401e-07 | 4.364e-06 |
257 | CEREBRAL CORTEX DEVELOPMENT | 32 | 105 | 2.424e-07 | 4.388e-06 |
258 | REGULATION OF HORMONE SECRETION | 60 | 262 | 2.736e-07 | 4.889e-06 |
259 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 104 | 541 | 2.723e-07 | 4.889e-06 |
260 | EPITHELIAL CELL DIFFERENTIATION | 97 | 495 | 2.742e-07 | 4.889e-06 |
261 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 104 | 541 | 2.723e-07 | 4.889e-06 |
262 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 14 | 3.254e-07 | 5.778e-06 |
263 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 41 | 154 | 3.372e-07 | 5.966e-06 |
264 | DEVELOPMENTAL CELL GROWTH | 26 | 77 | 3.477e-07 | 6.128e-06 |
265 | NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 34 | 117 | 3.648e-07 | 6.406e-06 |
266 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 33 | 112 | 3.792e-07 | 6.634e-06 |
267 | GLAND DEVELOPMENT | 81 | 395 | 3.905e-07 | 6.805e-06 |
268 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 39 | 144 | 4.005e-07 | 6.954e-06 |
269 | MUSCLE CELL DEVELOPMENT | 36 | 128 | 4.071e-07 | 7.041e-06 |
270 | REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 21 | 55 | 4.487e-07 | 7.733e-06 |
271 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 62 | 278 | 4.665e-07 | 8.009e-06 |
272 | MUCOPOLYSACCHARIDE METABOLIC PROCESS | 32 | 108 | 4.928e-07 | 8.429e-06 |
273 | ACTIN FILAMENT BASED MOVEMENT | 29 | 93 | 5.127e-07 | 8.739e-06 |
274 | CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 13 | 24 | 5.821e-07 | 9.885e-06 |
275 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 33 | 114 | 5.944e-07 | 1.006e-05 |
276 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 17 | 39 | 6.105e-07 | 1.029e-05 |
277 | REGULATION OF SECRETION | 126 | 699 | 6.165e-07 | 1.036e-05 |
278 | REGULATION OF DENDRITIC SPINE DEVELOPMENT | 21 | 56 | 6.385e-07 | 1.065e-05 |
279 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 21 | 56 | 6.385e-07 | 1.065e-05 |
280 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 40 | 152 | 6.48e-07 | 1.077e-05 |
281 | APPENDAGE DEVELOPMENT | 43 | 169 | 6.821e-07 | 1.126e-05 |
282 | LIMB DEVELOPMENT | 43 | 169 | 6.821e-07 | 1.126e-05 |
283 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 70 | 7.084e-07 | 1.165e-05 |
284 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 36 | 131 | 7.533e-07 | 1.234e-05 |
285 | MEMBRANE DEPOLARIZATION | 22 | 61 | 7.602e-07 | 1.241e-05 |
286 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 151 | 876 | 7.792e-07 | 1.268e-05 |
287 | METENCEPHALON DEVELOPMENT | 30 | 100 | 8.285e-07 | 1.343e-05 |
288 | REGULATION OF CARDIAC MUSCLE CONTRACTION | 23 | 66 | 8.657e-07 | 1.399e-05 |
289 | CELL COMMUNICATION BY ELECTRICAL COUPLING | 10 | 15 | 8.723e-07 | 1.404e-05 |
290 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 33 | 116 | 9.185e-07 | 1.469e-05 |
291 | PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION | 33 | 116 | 9.185e-07 | 1.469e-05 |
292 | POSITIVE REGULATION OF AXON EXTENSION | 16 | 36 | 9.498e-07 | 1.513e-05 |
293 | REGULATION OF PROTEIN IMPORT | 45 | 183 | 1.06e-06 | 1.683e-05 |
294 | AMINOGLYCAN METABOLIC PROCESS | 42 | 166 | 1.074e-06 | 1.7e-05 |
295 | REGULATION OF HEART RATE | 27 | 86 | 1.08e-06 | 1.703e-05 |
296 | REGULATION OF RECEPTOR ACTIVITY | 33 | 117 | 1.136e-06 | 1.786e-05 |
297 | EMBRYONIC ORGAN MORPHOGENESIS | 61 | 279 | 1.167e-06 | 1.826e-05 |
298 | REGULATION OF ION HOMEOSTASIS | 48 | 201 | 1.17e-06 | 1.826e-05 |
299 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 49 | 207 | 1.195e-06 | 1.86e-05 |
300 | PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 58 | 1.254e-06 | 1.944e-05 |
301 | ENDOTHELIAL CELL DIFFERENTIATION | 24 | 72 | 1.268e-06 | 1.961e-05 |
302 | LUNG MORPHOGENESIS | 18 | 45 | 1.331e-06 | 2.051e-05 |
303 | REGULATION OF CARTILAGE DEVELOPMENT | 22 | 63 | 1.432e-06 | 2.199e-05 |
304 | CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 12 | 22 | 1.451e-06 | 2.221e-05 |
305 | CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 16 | 37 | 1.49e-06 | 2.274e-05 |
306 | NERVE DEVELOPMENT | 23 | 68 | 1.575e-06 | 2.394e-05 |
307 | REGULATION OF PEPTIDE SECRETION | 49 | 209 | 1.608e-06 | 2.437e-05 |
308 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 30 | 103 | 1.651e-06 | 2.478e-05 |
309 | REGULATION OF CYTOPLASMIC TRANSPORT | 92 | 481 | 1.644e-06 | 2.478e-05 |
310 | REGULATION OF VASCULATURE DEVELOPMENT | 53 | 233 | 1.649e-06 | 2.478e-05 |
311 | REGULATION OF ORGAN GROWTH | 24 | 73 | 1.68e-06 | 2.505e-05 |
312 | NEGATIVE REGULATION OF PHOSPHORYLATION | 83 | 422 | 1.679e-06 | 2.505e-05 |
313 | REGULATION OF NEURON APOPTOTIC PROCESS | 46 | 192 | 1.759e-06 | 2.615e-05 |
314 | REGULATION OF EMBRYONIC DEVELOPMENT | 32 | 114 | 1.841e-06 | 2.728e-05 |
315 | REGULATION OF TRANSFERASE ACTIVITY | 159 | 946 | 1.878e-06 | 2.774e-05 |
316 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 18 | 46 | 1.947e-06 | 2.867e-05 |
317 | NEURON CELL CELL ADHESION | 10 | 16 | 2.079e-06 | 3.052e-05 |
318 | NEGATIVE REGULATION OF CELL GROWTH | 42 | 170 | 2.097e-06 | 3.069e-05 |
319 | LIPID PHOSPHORYLATION | 29 | 99 | 2.153e-06 | 3.14e-05 |
320 | NEGATIVE REGULATION OF TRANSPORT | 88 | 458 | 2.268e-06 | 3.297e-05 |
321 | SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 16 | 38 | 2.293e-06 | 3.324e-05 |
322 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 89 | 465 | 2.348e-06 | 3.373e-05 |
323 | DIGESTIVE SYSTEM DEVELOPMENT | 38 | 148 | 2.341e-06 | 3.373e-05 |
324 | POSITIVE REGULATION OF CELL GROWTH | 38 | 148 | 2.341e-06 | 3.373e-05 |
325 | CHONDROCYTE DIFFERENTIATION | 21 | 60 | 2.369e-06 | 3.381e-05 |
326 | OLIGODENDROCYTE DIFFERENTIATION | 21 | 60 | 2.369e-06 | 3.381e-05 |
327 | REGULATION OF INTRACELLULAR TRANSPORT | 112 | 621 | 2.518e-06 | 3.584e-05 |
328 | NEGATIVE REGULATION OF AXONOGENESIS | 22 | 65 | 2.608e-06 | 3.7e-05 |
329 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 121 | 684 | 2.713e-06 | 3.837e-05 |
330 | ENDOTHELIUM DEVELOPMENT | 27 | 90 | 2.888e-06 | 4.037e-05 |
331 | REGULATION OF CELL MATRIX ADHESION | 27 | 90 | 2.888e-06 | 4.037e-05 |
332 | MESONEPHROS DEVELOPMENT | 27 | 90 | 2.888e-06 | 4.037e-05 |
333 | MULTI ORGANISM BEHAVIOR | 24 | 75 | 2.889e-06 | 4.037e-05 |
334 | ADULT LOCOMOTORY BEHAVIOR | 25 | 80 | 2.938e-06 | 4.093e-05 |
335 | REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS | 39 | 155 | 2.967e-06 | 4.121e-05 |
336 | REGULATION OF PEPTIDE TRANSPORT | 56 | 256 | 3.095e-06 | 4.285e-05 |
337 | CELL PROLIFERATION | 119 | 672 | 3.113e-06 | 4.298e-05 |
338 | SPINAL CORD DEVELOPMENT | 30 | 106 | 3.176e-06 | 4.359e-05 |
339 | CEREBRAL CORTEX CELL MIGRATION | 17 | 43 | 3.167e-06 | 4.359e-05 |
340 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 155 | 926 | 3.222e-06 | 4.409e-05 |
341 | REGULATION OF CYTOSKELETON ORGANIZATION | 94 | 502 | 3.254e-06 | 4.44e-05 |
342 | REGULATION OF AXON GUIDANCE | 16 | 39 | 3.464e-06 | 4.712e-05 |
343 | ION TRANSPORT | 201 | 1262 | 3.685e-06 | 4.999e-05 |
344 | REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 47 | 203 | 3.752e-06 | 5.075e-05 |
345 | REGULATION OF PROTEIN LOCALIZATION | 158 | 950 | 3.768e-06 | 5.082e-05 |
346 | RESPONSE TO DRUG | 83 | 431 | 3.979e-06 | 5.335e-05 |
347 | ACTIN FILAMENT ORGANIZATION | 42 | 174 | 3.973e-06 | 5.335e-05 |
348 | REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 18 | 48 | 4.001e-06 | 5.349e-05 |
349 | REGULATION OF HORMONE LEVELS | 90 | 478 | 4.153e-06 | 5.537e-05 |
350 | NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 35 | 135 | 4.562e-06 | 6.048e-05 |
351 | CELL GROWTH | 35 | 135 | 4.562e-06 | 6.048e-05 |
352 | REGULATION OF BODY FLUID LEVELS | 94 | 506 | 4.586e-06 | 6.062e-05 |
353 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 22 | 67 | 4.607e-06 | 6.073e-05 |
354 | NEURON PROJECTION EXTENSION | 19 | 53 | 4.733e-06 | 6.221e-05 |
355 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 110 | 616 | 4.945e-06 | 6.481e-05 |
356 | REGULATION OF WNT SIGNALING PATHWAY | 64 | 310 | 4.969e-06 | 6.495e-05 |
357 | REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 48 | 211 | 4.986e-06 | 6.498e-05 |
358 | EXTRACELLULAR STRUCTURE ORGANIZATION | 63 | 304 | 5.162e-06 | 6.709e-05 |
359 | DIVALENT INORGANIC CATION HOMEOSTASIS | 69 | 343 | 5.543e-06 | 7.182e-05 |
360 | SEMAPHORIN PLEXIN SIGNALING PATHWAY | 15 | 36 | 5.557e-06 | 7.182e-05 |
361 | NEUROEPITHELIAL CELL DIFFERENTIATION | 21 | 63 | 5.769e-06 | 7.436e-05 |
362 | REGULATION OF CELL JUNCTION ASSEMBLY | 22 | 68 | 6.058e-06 | 7.786e-05 |
363 | PROTEOGLYCAN METABOLIC PROCESS | 25 | 83 | 6.146e-06 | 7.878e-05 |
364 | SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 11 | 21 | 6.801e-06 | 8.669e-05 |
365 | SIALYLATION | 11 | 21 | 6.801e-06 | 8.669e-05 |
366 | REGULATION OF NEUROTRANSMITTER TRANSPORT | 21 | 64 | 7.639e-06 | 9.711e-05 |
367 | POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 25 | 84 | 7.779e-06 | 9.862e-05 |
368 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 18 | 50 | 7.832e-06 | 9.903e-05 |
369 | SYNAPSE ASSEMBLY | 22 | 69 | 7.91e-06 | 9.975e-05 |
370 | REGULATION OF DENDRITE MORPHOGENESIS | 23 | 74 | 8.007e-06 | 0.0001004 |
371 | ACTIN MEDIATED CELL CONTRACTION | 23 | 74 | 8.007e-06 | 0.0001004 |
372 | CARDIAC CHAMBER DEVELOPMENT | 36 | 144 | 8.197e-06 | 0.0001025 |
373 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 100 | 554 | 8.283e-06 | 0.000103 |
374 | MEMBRANE ASSEMBLY | 12 | 25 | 8.298e-06 | 0.000103 |
375 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 12 | 25 | 8.298e-06 | 0.000103 |
376 | SIGNAL RELEASE | 41 | 173 | 8.333e-06 | 0.0001031 |
377 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 34 | 133 | 8.631e-06 | 0.0001065 |
378 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 61 | 296 | 8.692e-06 | 0.0001068 |
379 | REGULATION OF NEURON DEATH | 54 | 252 | 8.7e-06 | 0.0001068 |
380 | COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 30 | 111 | 8.791e-06 | 0.0001076 |
381 | REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 13 | 29 | 8.934e-06 | 0.0001088 |
382 | POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 13 | 29 | 8.934e-06 | 0.0001088 |
383 | REGULATION OF COLLATERAL SPROUTING | 10 | 18 | 9.078e-06 | 0.00011 |
384 | SMOOTH MUSCLE TISSUE DEVELOPMENT | 10 | 18 | 9.078e-06 | 0.00011 |
385 | SYNAPTIC VESICLE LOCALIZATION | 29 | 106 | 9.536e-06 | 0.0001152 |
386 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 20 | 60 | 9.573e-06 | 0.0001154 |
387 | ARTERY DEVELOPMENT | 23 | 75 | 1.027e-05 | 0.0001228 |
388 | NEURAL PRECURSOR CELL PROLIFERATION | 22 | 70 | 1.026e-05 | 0.0001228 |
389 | SENSORY PERCEPTION OF PAIN | 23 | 75 | 1.027e-05 | 0.0001228 |
390 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 124 | 724 | 1.04e-05 | 0.0001241 |
391 | AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 16 | 42 | 1.081e-05 | 0.0001287 |
392 | CALCIUM ION TRANSPORT | 49 | 223 | 1.096e-05 | 0.0001301 |
393 | REGULATION OF CAMP METABOLIC PROCESS | 33 | 129 | 1.145e-05 | 0.0001356 |
394 | NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 8 | 12 | 1.177e-05 | 0.0001383 |
395 | AXON EXTENSION INVOLVED IN AXON GUIDANCE | 8 | 12 | 1.177e-05 | 0.0001383 |
396 | WOUND HEALING | 87 | 470 | 1.183e-05 | 0.0001383 |
397 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 87 | 470 | 1.183e-05 | 0.0001383 |
398 | REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 8 | 12 | 1.177e-05 | 0.0001383 |
399 | EPITHELIAL TO MESENCHYMAL TRANSITION | 19 | 56 | 1.191e-05 | 0.0001389 |
400 | POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 20 | 61 | 1.267e-05 | 0.0001471 |
401 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 48 | 218 | 1.266e-05 | 0.0001471 |
402 | INOSITOL LIPID MEDIATED SIGNALING | 32 | 124 | 1.273e-05 | 0.0001473 |
403 | CALCIUM ION REGULATED EXOCYTOSIS | 24 | 81 | 1.277e-05 | 0.0001474 |
404 | DIVALENT INORGANIC CATION TRANSPORT | 56 | 268 | 1.309e-05 | 0.0001508 |
405 | GLAND MORPHOGENESIS | 27 | 97 | 1.355e-05 | 0.0001557 |
406 | MEMBRANE BIOGENESIS | 13 | 30 | 1.407e-05 | 0.0001604 |
407 | SMOOTH MUSCLE CELL DIFFERENTIATION | 13 | 30 | 1.407e-05 | 0.0001604 |
408 | CELL MATRIX ADHESION | 31 | 119 | 1.41e-05 | 0.0001604 |
409 | REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 13 | 30 | 1.407e-05 | 0.0001604 |
410 | INNER EAR MORPHOGENESIS | 26 | 92 | 1.447e-05 | 0.0001642 |
411 | METAL ION TRANSPORT | 103 | 582 | 1.451e-05 | 0.0001643 |
412 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 28 | 103 | 1.537e-05 | 0.0001736 |
413 | ACTOMYOSIN STRUCTURE ORGANIZATION | 23 | 77 | 1.661e-05 | 0.0001867 |
414 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 23 | 77 | 1.661e-05 | 0.0001867 |
415 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 20 | 62 | 1.665e-05 | 0.0001867 |
416 | SKELETAL MUSCLE ORGAN DEVELOPMENT | 34 | 137 | 1.706e-05 | 0.0001908 |
417 | REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 10 | 19 | 1.713e-05 | 0.0001912 |
418 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 42 | 184 | 1.735e-05 | 0.0001932 |
419 | DIGESTIVE TRACT MORPHOGENESIS | 17 | 48 | 1.789e-05 | 0.0001982 |
420 | MYOFIBRIL ASSEMBLY | 17 | 48 | 1.789e-05 | 0.0001982 |
421 | REGULATION OF WOUND HEALING | 32 | 126 | 1.81e-05 | 2e-04 |
422 | REGULATION OF CATION CHANNEL ACTIVITY | 25 | 88 | 1.903e-05 | 0.0002098 |
423 | NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 18 | 53 | 1.979e-05 | 0.0002177 |
424 | POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 14 | 35 | 1.999e-05 | 0.0002193 |
425 | STRIATED MUSCLE CONTRACTION | 27 | 99 | 2.032e-05 | 0.0002225 |
426 | REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 11 | 23 | 2.08e-05 | 0.0002267 |
427 | INNERVATION | 11 | 23 | 2.08e-05 | 0.0002267 |
428 | RENAL TUBULE DEVELOPMENT | 23 | 78 | 2.095e-05 | 0.0002278 |
429 | HIPPOCAMPUS DEVELOPMENT | 22 | 73 | 2.157e-05 | 0.000234 |
430 | ORGAN GROWTH | 21 | 68 | 2.186e-05 | 0.0002364 |
431 | RESPONSE TO BMP | 26 | 94 | 2.195e-05 | 0.0002364 |
432 | CELLULAR RESPONSE TO BMP STIMULUS | 26 | 94 | 2.195e-05 | 0.0002364 |
433 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 81 | 437 | 2.221e-05 | 0.0002387 |
434 | EPITHELIAL CELL DEVELOPMENT | 42 | 186 | 2.285e-05 | 0.0002444 |
435 | PEPTIDYL TYROSINE MODIFICATION | 42 | 186 | 2.285e-05 | 0.0002444 |
436 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 17 | 49 | 2.44e-05 | 0.0002586 |
437 | GLOMERULUS DEVELOPMENT | 17 | 49 | 2.44e-05 | 0.0002586 |
438 | REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 17 | 49 | 2.44e-05 | 0.0002586 |
439 | CARDIAC CELL DEVELOPMENT | 17 | 49 | 2.44e-05 | 0.0002586 |
440 | LIMBIC SYSTEM DEVELOPMENT | 27 | 100 | 2.474e-05 | 0.0002617 |
441 | POSITIVE REGULATION OF ION TRANSPORT | 50 | 236 | 2.532e-05 | 0.0002671 |
442 | CHEMICAL HOMEOSTASIS | 143 | 874 | 2.544e-05 | 0.0002679 |
443 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 56 | 274 | 2.553e-05 | 0.0002681 |
444 | CELLULAR RESPONSE TO ACID CHEMICAL | 40 | 175 | 2.631e-05 | 0.0002745 |
445 | REGULATION OF STRIATED MUSCLE CONTRACTION | 23 | 79 | 2.629e-05 | 0.0002745 |
446 | POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 40 | 175 | 2.631e-05 | 0.0002745 |
447 | PHOSPHORYLATION | 191 | 1228 | 2.804e-05 | 0.0002919 |
448 | SYNAPTIC VESICLE CYCLE | 25 | 90 | 2.897e-05 | 0.0003009 |
449 | EAR MORPHOGENESIS | 29 | 112 | 2.976e-05 | 0.0003084 |
450 | RESPONSE TO KETONE | 41 | 182 | 3.013e-05 | 0.0003115 |
451 | MELANOCYTE DIFFERENTIATION | 10 | 20 | 3.064e-05 | 0.0003154 |
452 | AXONAL FASCICULATION | 10 | 20 | 3.064e-05 | 0.0003154 |
453 | REGULATION OF ADHERENS JUNCTION ORGANIZATION | 17 | 50 | 3.293e-05 | 0.0003383 |
454 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 22 | 75 | 3.439e-05 | 0.0003525 |
455 | REGULATION OF SPROUTING ANGIOGENESIS | 12 | 28 | 3.455e-05 | 0.0003533 |
456 | NEGATIVE REGULATION OF NEURON DEATH | 39 | 171 | 3.475e-05 | 0.0003546 |
457 | RENAL SYSTEM PROCESS | 27 | 102 | 3.629e-05 | 0.0003695 |
458 | NEUROMUSCULAR PROCESS | 26 | 97 | 3.979e-05 | 0.0004042 |
459 | REGULATION OF CALCIUM MEDIATED SIGNALING | 22 | 76 | 4.306e-05 | 0.0004366 |
460 | POSITIVE REGULATION OF CHEMOTAXIS | 30 | 120 | 4.494e-05 | 0.0004546 |
461 | POSITIVE REGULATION OF CELL DEATH | 104 | 605 | 4.535e-05 | 0.0004577 |
462 | CELLULAR CHEMICAL HOMEOSTASIS | 99 | 570 | 4.548e-05 | 0.000458 |
463 | REGULATION OF PROTEIN POLYMERIZATION | 39 | 173 | 4.575e-05 | 0.0004597 |
464 | FOREBRAIN GENERATION OF NEURONS | 20 | 66 | 4.616e-05 | 0.0004629 |
465 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 19 | 61 | 4.658e-05 | 0.0004661 |
466 | REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 28 | 109 | 4.728e-05 | 0.0004721 |
467 | NEURON RECOGNITION | 13 | 33 | 4.784e-05 | 0.0004756 |
468 | RESPONSE TO ACID CHEMICAL | 62 | 319 | 4.774e-05 | 0.0004756 |
469 | REGULATION OF HEART GROWTH | 15 | 42 | 4.941e-05 | 0.0004902 |
470 | REGULATION OF ORGAN MORPHOGENESIS | 50 | 242 | 5.04e-05 | 0.000499 |
471 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 49 | 236 | 5.233e-05 | 0.0005159 |
472 | NEGATIVE REGULATION OF ORGAN GROWTH | 10 | 21 | 5.232e-05 | 0.0005159 |
473 | PIGMENT CELL DIFFERENTIATION | 12 | 29 | 5.263e-05 | 0.0005166 |
474 | REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 12 | 29 | 5.263e-05 | 0.0005166 |
475 | NEPHRON EPITHELIUM DEVELOPMENT | 25 | 93 | 5.274e-05 | 0.0005167 |
476 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 30 | 121 | 5.311e-05 | 0.0005191 |
477 | POSITIVE REGULATION OF ORGAN GROWTH | 14 | 38 | 5.912e-05 | 0.0005767 |
478 | CYCLIC NUCLEOTIDE METABOLIC PROCESS | 18 | 57 | 5.98e-05 | 0.0005821 |
479 | REGULATION OF BLOOD PRESSURE | 38 | 169 | 6.034e-05 | 0.0005862 |
480 | VASCULAR PROCESS IN CIRCULATORY SYSTEM | 37 | 163 | 6.061e-05 | 0.0005875 |
481 | REGULATION OF ERK1 AND ERK2 CASCADE | 49 | 238 | 6.544e-05 | 0.000633 |
482 | VESICLE MEDIATED TRANSPORT | 190 | 1239 | 6.706e-05 | 0.000647 |
483 | OSSIFICATION | 51 | 251 | 6.716e-05 | 0.000647 |
484 | PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 34 | 6.913e-05 | 0.0006619 |
485 | FOREBRAIN NEURON DEVELOPMENT | 13 | 34 | 6.913e-05 | 0.0006619 |
486 | TRANSMEMBRANE TRANSPORT | 171 | 1098 | 6.911e-05 | 0.0006619 |
487 | HORMONE MEDIATED SIGNALING PATHWAY | 36 | 158 | 6.971e-05 | 0.000666 |
488 | SKELETAL SYSTEM MORPHOGENESIS | 43 | 201 | 7.135e-05 | 0.0006803 |
489 | REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 16 | 48 | 7.336e-05 | 0.000698 |
490 | FAT CELL DIFFERENTIATION | 27 | 106 | 7.497e-05 | 0.0007119 |
491 | PATTERN SPECIFICATION PROCESS | 76 | 418 | 7.579e-05 | 0.0007182 |
492 | TISSUE MIGRATION | 23 | 84 | 7.602e-05 | 0.000719 |
493 | NEGATIVE REGULATION OF WOUND HEALING | 18 | 58 | 7.723e-05 | 0.0007289 |
494 | GANGLIOSIDE BIOSYNTHETIC PROCESS | 9 | 18 | 7.761e-05 | 0.000731 |
495 | REGULATION OF NEURON MIGRATION | 12 | 30 | 7.833e-05 | 0.0007363 |
496 | RHYTHMIC PROCESS | 58 | 298 | 7.91e-05 | 0.0007406 |
497 | ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 33 | 141 | 7.902e-05 | 0.0007406 |
498 | HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 35 | 153 | 8.013e-05 | 0.0007486 |
499 | ION TRANSMEMBRANE TRANSPORT | 133 | 822 | 8.163e-05 | 0.0007612 |
500 | COCHLEA DEVELOPMENT | 14 | 39 | 8.227e-05 | 0.0007656 |
501 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 41 | 190 | 8.481e-05 | 0.0007877 |
502 | BONE CELL DEVELOPMENT | 10 | 22 | 8.579e-05 | 0.0007936 |
503 | CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 10 | 22 | 8.579e-05 | 0.0007936 |
504 | REGULATION OF RESPONSE TO WOUNDING | 75 | 413 | 8.766e-05 | 0.0008093 |
505 | REGULATION OF MAP KINASE ACTIVITY | 61 | 319 | 8.877e-05 | 0.0008179 |
506 | REGULATION OF SEQUESTERING OF CALCIUM ION | 27 | 107 | 8.915e-05 | 0.0008198 |
507 | PEPTIDYL SERINE MODIFICATION | 34 | 148 | 9.204e-05 | 0.0008421 |
508 | CELL CYCLE ARREST | 35 | 154 | 9.211e-05 | 0.0008421 |
509 | EYE DEVELOPMENT | 62 | 326 | 9.179e-05 | 0.0008421 |
510 | PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 20 | 69 | 9.262e-05 | 0.0008451 |
511 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 104 | 616 | 9.398e-05 | 0.0008557 |
512 | CELL JUNCTION ORGANIZATION | 40 | 185 | 9.825e-05 | 0.0008912 |
513 | RESPONSE TO MONOAMINE | 13 | 35 | 9.817e-05 | 0.0008912 |
514 | LIPID MODIFICATION | 44 | 210 | 9.867e-05 | 0.0008932 |
515 | CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 43 | 204 | 0.000102 | 0.0009214 |
516 | POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 8 | 15 | 0.0001102 | 0.0009918 |
517 | CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 8 | 15 | 0.0001102 | 0.0009918 |
518 | DEVELOPMENTAL PIGMENTATION | 14 | 40 | 0.0001129 | 0.001014 |
519 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 285 | 1977 | 0.0001137 | 0.001019 |
520 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 45 | 218 | 0.0001194 | 0.001068 |
521 | REGULATION OF ACTIN FILAMENT LENGTH | 35 | 156 | 0.0001211 | 0.001081 |
522 | ENDOTHELIAL CELL DEVELOPMENT | 15 | 45 | 0.0001225 | 0.00109 |
523 | SPROUTING ANGIOGENESIS | 15 | 45 | 0.0001225 | 0.00109 |
524 | METANEPHROS DEVELOPMENT | 22 | 81 | 0.000123 | 0.001092 |
525 | REGULATION OF BINDING | 55 | 283 | 0.0001242 | 0.001101 |
526 | POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS | 27 | 109 | 0.0001249 | 0.001105 |
527 | REGULATION OF ORGANELLE ORGANIZATION | 180 | 1178 | 0.0001264 | 0.001116 |
528 | POSITIVE REGULATION OF HEART GROWTH | 11 | 27 | 0.000128 | 0.001119 |
529 | HIPPO SIGNALING | 11 | 27 | 0.000128 | 0.001119 |
530 | MOTOR NEURON AXON GUIDANCE | 11 | 27 | 0.000128 | 0.001119 |
531 | NEGATIVE REGULATION OF AXON GUIDANCE | 11 | 27 | 0.000128 | 0.001119 |
532 | REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 11 | 27 | 0.000128 | 0.001119 |
533 | REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 9 | 19 | 0.000132 | 0.001148 |
534 | VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 9 | 19 | 0.000132 | 0.001148 |
535 | POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 9 | 19 | 0.000132 | 0.001148 |
536 | NEUROTROPHIN SIGNALING PATHWAY | 10 | 23 | 0.0001358 | 0.001179 |
537 | POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS | 31 | 133 | 0.0001389 | 0.001201 |
538 | POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 31 | 133 | 0.0001389 | 0.001201 |
539 | CARDIAC CHAMBER MORPHOGENESIS | 26 | 104 | 0.0001407 | 0.001214 |
540 | NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 20 | 71 | 0.0001431 | 0.001233 |
541 | SENSORY ORGAN MORPHOGENESIS | 48 | 239 | 0.0001451 | 0.001246 |
542 | ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 7 | 12 | 0.0001449 | 0.001246 |
543 | KIDNEY MORPHOGENESIS | 22 | 82 | 0.0001496 | 0.001282 |
544 | REGULATION OF CARDIAC CONDUCTION | 19 | 66 | 0.000152 | 0.0013 |
545 | POSITIVE REGULATION OF CYCLASE ACTIVITY | 18 | 61 | 0.0001592 | 0.00136 |
546 | ENDOCARDIAL CUSHION DEVELOPMENT | 12 | 32 | 0.0001632 | 0.001385 |
547 | IMMUNE SYSTEM DEVELOPMENT | 98 | 582 | 0.0001632 | 0.001385 |
548 | REGULATION OF SODIUM ION TRANSPORT | 21 | 77 | 0.0001631 | 0.001385 |
549 | REGULATION OF STEM CELL PROLIFERATION | 23 | 88 | 0.0001641 | 0.001388 |
550 | OUTFLOW TRACT MORPHOGENESIS | 17 | 56 | 0.000164 | 0.001388 |
551 | REGULATION OF NEUROTRANSMITTER SECRETION | 16 | 51 | 0.0001654 | 0.001396 |
552 | CYTOSOLIC TRANSPORT | 44 | 215 | 0.0001731 | 0.001459 |
553 | CELLULAR HOMEOSTASIS | 111 | 676 | 0.0001735 | 0.00146 |
554 | ION HOMEOSTASIS | 97 | 576 | 0.0001751 | 0.00147 |
555 | REGULATION OF POTASSIUM ION TRANSPORT | 22 | 83 | 0.0001812 | 0.001519 |
556 | CELL JUNCTION ASSEMBLY | 30 | 129 | 0.0001842 | 0.001541 |
557 | PLASMA MEMBRANE ORGANIZATION | 42 | 203 | 0.0001875 | 0.001565 |
558 | NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 11 | 28 | 0.0001884 | 0.001565 |
559 | REGULATION OF KERATINOCYTE PROLIFERATION | 11 | 28 | 0.0001884 | 0.001565 |
560 | LONG TERM MEMORY | 11 | 28 | 0.0001884 | 0.001565 |
561 | CARDIAC VENTRICLE DEVELOPMENT | 26 | 106 | 0.000196 | 0.001625 |
562 | REGULATION OF RESPIRATORY SYSTEM PROCESS | 8 | 16 | 0.0001976 | 0.001627 |
563 | POSITIVE REGULATION OF ACTIN NUCLEATION | 8 | 16 | 0.0001976 | 0.001627 |
564 | POSITIVE REGULATION OF CAMP METABOLIC PROCESS | 23 | 89 | 0.0001969 | 0.001627 |
565 | RESPONSE TO EPINEPHRINE | 8 | 16 | 0.0001976 | 0.001627 |
566 | RESPONSE TO AMINO ACID | 27 | 112 | 0.0002027 | 0.001667 |
567 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 28 | 118 | 0.0002077 | 0.001704 |
568 | IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 10 | 24 | 0.0002082 | 0.001706 |
569 | RELAXATION OF MUSCLE | 9 | 20 | 0.000215 | 0.001758 |
570 | RESPONSE TO PEPTIDE | 72 | 404 | 0.0002162 | 0.001761 |
571 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 72 | 404 | 0.0002162 | 0.001761 |
572 | REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 20 | 73 | 0.0002164 | 0.001761 |
573 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 55 | 289 | 0.000218 | 0.00177 |
574 | EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 12 | 33 | 0.000229 | 0.001857 |
575 | OVULATION CYCLE | 27 | 113 | 0.0002369 | 0.001917 |
576 | CELLULAR RESPONSE TO OXYGEN LEVELS | 32 | 143 | 0.0002434 | 0.001963 |
577 | NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 32 | 143 | 0.0002434 | 0.001963 |
578 | STEROID HORMONE MEDIATED SIGNALING PATHWAY | 29 | 125 | 0.0002443 | 0.001967 |
579 | REGULATION OF MUSCLE ADAPTATION | 18 | 63 | 0.0002494 | 0.002004 |
580 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 40 | 193 | 0.0002535 | 0.002033 |
581 | NEGATIVE REGULATION OF AXON EXTENSION | 13 | 38 | 0.0002562 | 0.002049 |
582 | REGULATION OF ACTION POTENTIAL | 13 | 38 | 0.0002562 | 0.002049 |
583 | REGULATION OF VESICLE MEDIATED TRANSPORT | 80 | 462 | 0.0002589 | 0.002066 |
584 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 25 | 102 | 0.000261 | 0.002079 |
585 | PALATE DEVELOPMENT | 22 | 85 | 0.0002624 | 0.002087 |
586 | NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 35 | 162 | 0.0002633 | 0.002091 |
587 | NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 34 | 156 | 0.0002692 | 0.002134 |
588 | STEM CELL DIVISION | 11 | 29 | 0.0002714 | 0.002136 |
589 | CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 14 | 43 | 0.000271 | 0.002136 |
590 | CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 11 | 29 | 0.0002714 | 0.002136 |
591 | NEUROBLAST PROLIFERATION | 11 | 29 | 0.0002714 | 0.002136 |
592 | POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 15 | 48 | 0.0002755 | 0.002165 |
593 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 43 | 213 | 0.0002783 | 0.00218 |
594 | MULTI MULTICELLULAR ORGANISM PROCESS | 43 | 213 | 0.0002783 | 0.00218 |
595 | SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL INTERNEURON MIGRATION | 7 | 13 | 0.0002819 | 0.002186 |
596 | REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NEUROLOGICAL SYSTEM PROCESS | 7 | 13 | 0.0002819 | 0.002186 |
597 | SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION | 7 | 13 | 0.0002819 | 0.002186 |
598 | CELL MIGRATION IN HINDBRAIN | 7 | 13 | 0.0002819 | 0.002186 |
599 | GLIAL CELL FATE COMMITMENT | 7 | 13 | 0.0002819 | 0.002186 |
600 | GANGLION DEVELOPMENT | 7 | 13 | 0.0002819 | 0.002186 |
601 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 42 | 207 | 0.000291 | 0.002253 |
602 | EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 10 | 25 | 0.0003106 | 0.002385 |
603 | STARTLE RESPONSE | 10 | 25 | 0.0003106 | 0.002385 |
604 | POSTSYNAPTIC MEMBRANE ORGANIZATION | 10 | 25 | 0.0003106 | 0.002385 |
605 | GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 10 | 25 | 0.0003106 | 0.002385 |
606 | POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 10 | 25 | 0.0003106 | 0.002385 |
607 | RESPONSE TO FLUID SHEAR STRESS | 12 | 34 | 0.0003163 | 0.002416 |
608 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 12 | 34 | 0.0003163 | 0.002416 |
609 | CAMP METABOLIC PROCESS | 12 | 34 | 0.0003163 | 0.002416 |
610 | RESPONSE TO CALCIUM ION | 27 | 115 | 0.0003209 | 0.002448 |
611 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 28 | 121 | 0.0003241 | 0.002468 |
612 | VASCULOGENESIS | 17 | 59 | 0.000329 | 0.002501 |
613 | REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 23 | 92 | 0.0003328 | 0.002526 |
614 | NEGATIVE REGULATION OF PLATELET ACTIVATION | 8 | 17 | 0.0003347 | 0.002528 |
615 | CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 8 | 17 | 0.0003347 | 0.002528 |
616 | REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 8 | 17 | 0.0003347 | 0.002528 |
617 | CELL DIFFERENTIATION IN HINDBRAIN | 9 | 21 | 0.000337 | 0.002537 |
618 | POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 9 | 21 | 0.000337 | 0.002537 |
619 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 13 | 39 | 0.0003432 | 0.002567 |
620 | LONG TERM SYNAPTIC POTENTIATION | 13 | 39 | 0.0003432 | 0.002567 |
621 | CELLULAR RESPONSE TO PEPTIDE | 52 | 274 | 0.0003418 | 0.002567 |
622 | POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 13 | 39 | 0.0003432 | 0.002567 |
623 | MYELOID CELL DEVELOPMENT | 14 | 44 | 0.0003548 | 0.00265 |
624 | NEGATIVE REGULATION OF CELL MATRIX ADHESION | 11 | 30 | 0.0003831 | 0.002848 |
625 | MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 11 | 30 | 0.0003831 | 0.002848 |
626 | REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 11 | 30 | 0.0003831 | 0.002848 |
627 | POSITIVE REGULATION OF BLOOD CIRCULATION | 23 | 93 | 0.0003935 | 0.00292 |
628 | NEGATIVE REGULATION OF CELL ADHESION | 44 | 223 | 0.0004007 | 0.002969 |
629 | WNT SIGNALING PATHWAY | 63 | 351 | 0.0004271 | 0.003159 |
630 | NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT | 27 | 117 | 0.0004301 | 0.003177 |
631 | NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 10 | 26 | 0.0004517 | 0.003325 |
632 | PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 15 | 50 | 0.0004514 | 0.003325 |
633 | CATION TRANSPORT | 125 | 796 | 0.00046 | 0.003366 |
634 | EXOCRINE SYSTEM DEVELOPMENT | 14 | 45 | 0.0004597 | 0.003366 |
635 | PROTEIN AUTOPHOSPHORYLATION | 39 | 192 | 0.0004589 | 0.003366 |
636 | REGIONALIZATION | 57 | 311 | 0.0004596 | 0.003366 |
637 | ORGANELLE LOCALIZATION | 72 | 415 | 0.0004842 | 0.003537 |
638 | REGULATION OF FAT CELL DIFFERENTIATION | 25 | 106 | 0.0004884 | 0.003562 |
639 | POSITIVE REGULATION OF LYASE ACTIVITY | 17 | 61 | 0.0005058 | 0.003654 |
640 | VOCALIZATION BEHAVIOR | 7 | 14 | 0.0005065 | 0.003654 |
641 | POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 7 | 14 | 0.0005065 | 0.003654 |
642 | POSITIVE REGULATION OF FATTY ACID OXIDATION | 7 | 14 | 0.0005065 | 0.003654 |
643 | CAMP CATABOLIC PROCESS | 7 | 14 | 0.0005065 | 0.003654 |
644 | POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 7 | 14 | 0.0005065 | 0.003654 |
645 | DETECTION OF CALCIUM ION | 7 | 14 | 0.0005065 | 0.003654 |
646 | NEGATIVE REGULATION OF MUSCLE CONTRACTION | 9 | 22 | 0.0005109 | 0.00368 |
647 | LEUKOCYTE DIFFERENTIATION | 54 | 292 | 0.000512 | 0.003682 |
648 | SMOOTHENED SIGNALING PATHWAY | 19 | 72 | 0.000517 | 0.003713 |
649 | POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 31 | 0.000531 | 0.003807 |
650 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 52 | 279 | 0.0005328 | 0.003814 |
651 | POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 8 | 18 | 0.0005404 | 0.003851 |
652 | RETINAL GANGLION CELL AXON GUIDANCE | 8 | 18 | 0.0005404 | 0.003851 |
653 | CENTROSOME LOCALIZATION | 8 | 18 | 0.0005404 | 0.003851 |
654 | REGULATION OF PROTEIN COMPLEX ASSEMBLY | 66 | 375 | 0.0005492 | 0.003908 |
655 | POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 34 | 162 | 0.000559 | 0.003971 |
656 | NEGATIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY | 25 | 107 | 0.000567 | 0.004022 |
657 | ARTERY MORPHOGENESIS | 15 | 51 | 0.0005707 | 0.004031 |
658 | NEGATIVE REGULATION OF CHEMOTAXIS | 15 | 51 | 0.0005707 | 0.004031 |
659 | REGULATION OF STEM CELL DIFFERENTIATION | 26 | 113 | 0.000571 | 0.004031 |
660 | NEGATIVE REGULATION OF BLOOD CIRCULATION | 12 | 36 | 0.0005765 | 0.004058 |
661 | POSITIVE REGULATION OF PROTEIN ACETYLATION | 12 | 36 | 0.0005765 | 0.004058 |
662 | REGULATION OF PROTEIN TARGETING | 56 | 307 | 0.0005781 | 0.004063 |
663 | INTRASPECIES INTERACTION BETWEEN ORGANISMS | 14 | 46 | 0.0005899 | 0.004127 |
664 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 14 | 46 | 0.0005899 | 0.004127 |
665 | SOCIAL BEHAVIOR | 14 | 46 | 0.0005899 | 0.004127 |
666 | CELL SUBSTRATE JUNCTION ASSEMBLY | 13 | 41 | 0.0005939 | 0.004131 |
667 | CELL FATE COMMITMENT | 44 | 227 | 0.0005939 | 0.004131 |
668 | GLUTAMATE RECEPTOR SIGNALING PATHWAY | 13 | 41 | 0.0005939 | 0.004131 |
669 | LUNG ALVEOLUS DEVELOPMENT | 13 | 41 | 0.0005939 | 0.004131 |
670 | HOMEOSTATIC PROCESS | 196 | 1337 | 0.0006047 | 0.004199 |
671 | CELL ACTIVATION | 93 | 568 | 0.0006191 | 0.004293 |
672 | CARDIAC VENTRICLE MORPHOGENESIS | 17 | 62 | 0.0006213 | 0.004296 |
673 | REGULATION OF SMOOTHENED SIGNALING PATHWAY | 17 | 62 | 0.0006213 | 0.004296 |
674 | ASSOCIATIVE LEARNING | 19 | 73 | 0.0006228 | 0.0043 |
675 | REGULATION OF CARDIAC MUSCLE CELL CONTRACTION | 10 | 27 | 0.0006421 | 0.0044 |
676 | REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 27 | 0.0006421 | 0.0044 |
677 | MAINTENANCE OF CELL NUMBER | 29 | 132 | 0.0006388 | 0.0044 |
678 | REGULATION OF CATENIN IMPORT INTO NUCLEUS | 10 | 27 | 0.0006421 | 0.0044 |
679 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 10 | 27 | 0.0006421 | 0.0044 |
680 | PROTEIN LOCALIZATION TO CELL PERIPHERY | 32 | 151 | 0.0006716 | 0.004596 |
681 | NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 41 | 209 | 0.0006987 | 0.004774 |
682 | CARDIAC SEPTUM DEVELOPMENT | 21 | 85 | 0.000701 | 0.004783 |
683 | SALIVARY GLAND DEVELOPMENT | 11 | 32 | 0.0007238 | 0.004902 |
684 | NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 11 | 32 | 0.0007238 | 0.004902 |
685 | POSITIVE REGULATION OF DENDRITE MORPHOGENESIS | 11 | 32 | 0.0007238 | 0.004902 |
686 | REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 11 | 32 | 0.0007238 | 0.004902 |
687 | NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 11 | 32 | 0.0007238 | 0.004902 |
688 | POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 6 | 11 | 0.0007272 | 0.004904 |
689 | POSITIVE REGULATION OF FIBROBLAST MIGRATION | 6 | 11 | 0.0007272 | 0.004904 |
690 | POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 6 | 11 | 0.0007272 | 0.004904 |
691 | PROSTATE GLAND MORPHOGENESIS | 9 | 23 | 0.0007521 | 0.005064 |
692 | REGULATION OF CALCIUM ION IMPORT | 24 | 103 | 0.0007543 | 0.005072 |
693 | GLIAL CELL MIGRATION | 12 | 37 | 0.0007626 | 0.005113 |
694 | REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 12 | 37 | 0.0007626 | 0.005113 |
695 | POSITIVE REGULATION OF GLUCOSE TRANSPORT | 13 | 42 | 0.0007683 | 0.005144 |
696 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 39 | 197 | 0.0007751 | 0.005174 |
697 | NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 39 | 197 | 0.0007751 | 0.005174 |
698 | CALCIUM ION TRANSMEMBRANE TRANSPORT | 33 | 159 | 0.0008195 | 0.005463 |
699 | VESICLE LOCALIZATION | 43 | 224 | 0.0008361 | 0.005551 |
700 | CELLULAR RESPONSE TO FLUID SHEAR STRESS | 8 | 19 | 0.0008374 | 0.005551 |
701 | NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 8 | 19 | 0.0008374 | 0.005551 |
702 | POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 8 | 19 | 0.0008374 | 0.005551 |
703 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 66 | 381 | 0.0008463 | 0.005601 |
704 | REGULATION OF HEAT GENERATION | 7 | 15 | 0.0008532 | 0.005623 |
705 | REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 7 | 15 | 0.0008532 | 0.005623 |
706 | VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 15 | 0.0008532 | 0.005623 |
707 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 90 | 552 | 0.0008597 | 0.005658 |
708 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 15 | 53 | 0.0008908 | 0.005824 |
709 | REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 19 | 75 | 0.0008912 | 0.005824 |
710 | MESONEPHRIC TUBULE MORPHOGENESIS | 15 | 53 | 0.0008908 | 0.005824 |
711 | CELLULAR RESPONSE TO AMINO ACID STIMULUS | 15 | 53 | 0.0008908 | 0.005824 |
712 | SKELETAL MUSCLE CELL DIFFERENTIATION | 15 | 53 | 0.0008908 | 0.005824 |
713 | REGULATION OF FIBROBLAST MIGRATION | 10 | 28 | 0.0008941 | 0.005835 |
714 | REGULATION OF PROTEIN ACETYLATION | 17 | 64 | 0.0009213 | 0.006004 |
715 | NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 29 | 135 | 0.0009341 | 0.006079 |
716 | COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 14 | 48 | 0.0009454 | 0.006144 |
717 | POTASSIUM ION TRANSPORT | 32 | 154 | 0.0009543 | 0.006193 |
718 | TUBE FORMATION | 28 | 129 | 0.0009574 | 0.006204 |
719 | CRANIAL NERVE DEVELOPMENT | 13 | 43 | 0.0009838 | 0.006366 |
720 | REGULATION OF ADENYLATE CYCLASE ACTIVITY | 18 | 70 | 0.0009985 | 0.006447 |
721 | DEVELOPMENTAL MATURATION | 38 | 193 | 0.000999 | 0.006447 |
722 | POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 23 | 99 | 0.001004 | 0.006469 |
723 | ODONTOGENESIS | 24 | 105 | 0.001007 | 0.006482 |
724 | REGENERATION | 33 | 161 | 0.001026 | 0.006597 |
725 | POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 19 | 76 | 0.001059 | 0.006797 |
726 | CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 9 | 24 | 0.001078 | 0.006883 |
727 | AXON REGENERATION | 9 | 24 | 0.001078 | 0.006883 |
728 | BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 9 | 24 | 0.001078 | 0.006883 |
729 | CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 9 | 24 | 0.001078 | 0.006883 |
730 | TRANSMISSION OF NERVE IMPULSE | 15 | 54 | 0.001101 | 0.007017 |
731 | ESTABLISHMENT OF CELL POLARITY | 21 | 88 | 0.001135 | 0.007224 |
732 | RESPONSE TO ALKALOID | 29 | 137 | 0.001192 | 0.007575 |
733 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 63 | 365 | 0.001201 | 0.007622 |
734 | BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 13 | 44 | 0.001248 | 0.007898 |
735 | NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 13 | 44 | 0.001248 | 0.007898 |
736 | REGULATION OF BMP SIGNALING PATHWAY | 19 | 77 | 0.001253 | 0.007922 |
737 | HEART VALVE DEVELOPMENT | 11 | 34 | 0.001284 | 0.008108 |
738 | ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 12 | 39 | 0.001287 | 0.008112 |
739 | RESPONSE TO CORTICOSTEROID | 35 | 176 | 0.00129 | 0.008122 |
740 | RESPONSE TO FATTY ACID | 20 | 83 | 0.001296 | 0.008149 |
741 | NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 6 | 12 | 0.001309 | 0.0082 |
742 | ROUNDABOUT SIGNALING PATHWAY | 6 | 12 | 0.001309 | 0.0082 |
743 | CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 6 | 12 | 0.001309 | 0.0082 |
744 | NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 15 | 55 | 0.001351 | 0.008446 |
745 | NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION | 7 | 16 | 0.001363 | 0.008446 |
746 | REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS | 7 | 16 | 0.001363 | 0.008446 |
747 | CARDIAC MYOFIBRIL ASSEMBLY | 7 | 16 | 0.001363 | 0.008446 |
748 | NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 7 | 16 | 0.001363 | 0.008446 |
749 | MEGAKARYOCYTE DEVELOPMENT | 7 | 16 | 0.001363 | 0.008446 |
750 | NEGATIVE REGULATION OF STRESS FIBER ASSEMBLY | 7 | 16 | 0.001363 | 0.008446 |
751 | POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 16 | 0.001363 | 0.008446 |
752 | GLYCOPROTEIN METABOLIC PROCESS | 61 | 353 | 0.001381 | 0.008547 |
753 | REGULATION OF AMINE TRANSPORT | 18 | 72 | 0.001418 | 0.008761 |
754 | ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 30 | 145 | 0.001452 | 0.00896 |
755 | RESPONSE TO ORGANOPHOSPHORUS | 29 | 139 | 0.001509 | 0.009296 |
756 | CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 9 | 25 | 0.00151 | 0.009296 |
757 | CALCIUM MEDIATED SIGNALING | 21 | 90 | 0.001538 | 0.009439 |
758 | REGULATION OF GLIOGENESIS | 21 | 90 | 0.001538 | 0.009439 |
759 | SMOOTH MUSCLE CONTRACTION | 13 | 45 | 0.001568 | 0.00961 |
760 | POSITIVE REGULATION OF CELL ADHESION | 64 | 376 | 0.001575 | 0.009645 |
761 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 160 | 1087 | 0.001586 | 0.009697 |
762 | NEGATIVE REGULATION OF CELL CYCLE | 72 | 433 | 0.001595 | 0.009739 |
763 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 17 | 67 | 0.001598 | 0.009743 |
764 | RESPONSE TO ESTRADIOL | 30 | 146 | 0.001626 | 0.0099 |
765 | RESPONSE TO ESTROGEN | 41 | 218 | 0.001634 | 0.009941 |
766 | CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 10 | 30 | 0.001641 | 0.009944 |
767 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 10 | 30 | 0.001641 | 0.009944 |
768 | CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 10 | 30 | 0.001641 | 0.009944 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 241 | 1199 | 9.881e-18 | 9.18e-15 |
2 | CYTOSKELETAL PROTEIN BINDING | 176 | 819 | 5.841e-16 | 2.713e-13 |
3 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 141 | 629 | 1.656e-14 | 5.129e-12 |
4 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 88 | 328 | 4.887e-14 | 1.135e-11 |
5 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 67 | 226 | 3.482e-13 | 6.47e-11 |
6 | REGULATORY REGION NUCLEIC ACID BINDING | 164 | 818 | 2.952e-12 | 4.281e-10 |
7 | MACROMOLECULAR COMPLEX BINDING | 250 | 1399 | 3.226e-12 | 4.281e-10 |
8 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 80 | 315 | 1.465e-11 | 1.701e-09 |
9 | PROTEIN KINASE ACTIVITY | 131 | 640 | 1.192e-10 | 1.231e-08 |
10 | PROTEIN DOMAIN SPECIFIC BINDING | 128 | 624 | 1.689e-10 | 1.569e-08 |
11 | DOUBLE STRANDED DNA BINDING | 148 | 764 | 4.611e-10 | 3.894e-08 |
12 | PROTEIN COMPLEX BINDING | 173 | 935 | 6.29e-10 | 4.869e-08 |
13 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 60 | 228 | 1.16e-09 | 8.293e-08 |
14 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 73 | 303 | 1.438e-09 | 8.906e-08 |
15 | ENZYME BINDING | 285 | 1737 | 1.394e-09 | 8.906e-08 |
16 | ACTIN BINDING | 88 | 393 | 1.608e-09 | 9.336e-08 |
17 | KINASE ACTIVITY | 157 | 842 | 2.319e-09 | 1.267e-07 |
18 | CALCIUM ION BINDING | 134 | 697 | 5.152e-09 | 2.659e-07 |
19 | SEQUENCE SPECIFIC DNA BINDING | 182 | 1037 | 1.453e-08 | 7.105e-07 |
20 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 81 | 371 | 2.357e-08 | 1.095e-06 |
21 | HEPARIN BINDING | 43 | 157 | 7.34e-08 | 3.247e-06 |
22 | MOLECULAR FUNCTION REGULATOR | 222 | 1353 | 1.115e-07 | 4.318e-06 |
23 | TUBULIN BINDING | 63 | 273 | 1.035e-07 | 4.318e-06 |
24 | RECEPTOR BINDING | 239 | 1476 | 1.071e-07 | 4.318e-06 |
25 | KINASE BINDING | 114 | 606 | 2.358e-07 | 8.424e-06 |
26 | PDZ DOMAIN BINDING | 29 | 90 | 2.349e-07 | 8.424e-06 |
27 | METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 85 | 417 | 2.66e-07 | 8.825e-06 |
28 | CELL ADHESION MOLECULE BINDING | 47 | 186 | 2.629e-07 | 8.825e-06 |
29 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 27 | 81 | 2.804e-07 | 8.981e-06 |
30 | CHEMOREPELLENT ACTIVITY | 14 | 27 | 4.329e-07 | 1.34e-05 |
31 | MICROTUBULE BINDING | 49 | 201 | 4.739e-07 | 1.42e-05 |
32 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 24 | 70 | 7.084e-07 | 2.056e-05 |
33 | GLYCOSAMINOGLYCAN BINDING | 49 | 205 | 8.836e-07 | 2.487e-05 |
34 | ION CHANNEL BINDING | 32 | 111 | 9.679e-07 | 2.645e-05 |
35 | CATION CHANNEL ACTIVITY | 64 | 298 | 1.236e-06 | 3.281e-05 |
36 | VOLTAGE GATED ION CHANNEL ACTIVITY | 46 | 190 | 1.29e-06 | 3.328e-05 |
37 | SULFUR COMPOUND BINDING | 53 | 234 | 1.891e-06 | 4.748e-05 |
38 | PROTEIN TYROSINE KINASE ACTIVITY | 43 | 176 | 2.186e-06 | 5.344e-05 |
39 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 86 | 445 | 2.312e-06 | 5.506e-05 |
40 | GATED CHANNEL ACTIVITY | 67 | 325 | 3.174e-06 | 7.371e-05 |
41 | TRANSLATION REPRESSOR ACTIVITY | 11 | 20 | 3.626e-06 | 8.215e-05 |
42 | GROWTH FACTOR BINDING | 33 | 123 | 3.803e-06 | 8.411e-05 |
43 | PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 88 | 464 | 3.92e-06 | 8.468e-05 |
44 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 163 | 992 | 5.415e-06 | 0.0001143 |
45 | SIALYLTRANSFERASE ACTIVITY | 11 | 21 | 6.801e-06 | 0.0001404 |
46 | IDENTICAL PROTEIN BINDING | 192 | 1209 | 7.39e-06 | 0.0001492 |
47 | LIPID BINDING | 115 | 657 | 7.914e-06 | 0.0001564 |
48 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 34 | 133 | 8.631e-06 | 0.0001636 |
49 | CALMODULIN BINDING | 42 | 179 | 8.479e-06 | 0.0001636 |
50 | TRANSCRIPTION FACTOR BINDING | 95 | 524 | 1.153e-05 | 0.0002141 |
51 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 18 | 53 | 1.979e-05 | 0.0003605 |
52 | SH3 DOMAIN BINDING | 30 | 116 | 2.242e-05 | 0.0004005 |
53 | BETA CATENIN BINDING | 24 | 84 | 2.5e-05 | 0.0004382 |
54 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 20 | 64 | 2.811e-05 | 0.0004748 |
55 | STEROID HORMONE RECEPTOR ACTIVITY | 19 | 59 | 2.764e-05 | 0.0004748 |
56 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 24 | 86 | 3.822e-05 | 0.0006341 |
57 | PROTEIN KINASE A BINDING | 15 | 42 | 4.941e-05 | 0.0008053 |
58 | NEUREXIN FAMILY PROTEIN BINDING | 8 | 14 | 5.737e-05 | 0.0009188 |
59 | VOLTAGE GATED CATION CHANNEL ACTIVITY | 32 | 134 | 6.676e-05 | 0.001048 |
60 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 15 | 43 | 6.766e-05 | 0.001048 |
61 | WNT ACTIVATED RECEPTOR ACTIVITY | 10 | 22 | 8.579e-05 | 0.001307 |
62 | CHANNEL REGULATOR ACTIVITY | 31 | 131 | 0.0001032 | 0.001546 |
63 | NEUROPILIN BINDING | 8 | 15 | 0.0001102 | 0.0016 |
64 | PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 8 | 15 | 0.0001102 | 0.0016 |
65 | TRANSMEMBRANE TRANSPORTER ACTIVITY | 156 | 997 | 0.0001138 | 0.001626 |
66 | CYTOKINE BINDING | 24 | 92 | 0.0001234 | 0.00171 |
67 | SCAFFOLD PROTEIN BINDING | 15 | 45 | 0.0001225 | 0.00171 |
68 | CAMP BINDING | 10 | 23 | 0.0001358 | 0.00182 |
69 | CYCLIC NUCLEOTIDE BINDING | 13 | 36 | 0.0001372 | 0.00182 |
70 | RNA POLYMERASE II TRANSCRIPTION COACTIVATOR ACTIVITY | 13 | 36 | 0.0001372 | 0.00182 |
71 | INTEGRIN BINDING | 26 | 105 | 0.0001663 | 0.002176 |
72 | PROTEIN HOMODIMERIZATION ACTIVITY | 117 | 722 | 0.0002018 | 0.002604 |
73 | VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 9 | 20 | 0.000215 | 0.002736 |
74 | RIBONUCLEOTIDE BINDING | 267 | 1860 | 0.0002502 | 0.003141 |
75 | TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING | 15 | 48 | 0.0002755 | 0.003412 |
76 | PHOSPHOLIPID BINDING | 65 | 360 | 0.0002954 | 0.003611 |
77 | CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 102 | 622 | 0.0003278 | 0.003954 |
78 | GROWTH FACTOR RECEPTOR BINDING | 29 | 129 | 0.0004287 | 0.005106 |
79 | GROWTH FACTOR ACTIVITY | 34 | 160 | 0.0004411 | 0.005187 |
80 | INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 88 | 527 | 0.0004535 | 0.005266 |
81 | DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 167 | 0.0004806 | 0.005513 |
82 | SMAD BINDING | 19 | 72 | 0.000517 | 0.005787 |
83 | SEMAPHORIN RECEPTOR BINDING | 9 | 22 | 0.0005109 | 0.005787 |
84 | VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 22 | 89 | 0.000525 | 0.005806 |
85 | POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 143 | 0.0005399 | 0.005901 |
86 | PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 15 | 51 | 0.0005707 | 0.006018 |
87 | PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 15 | 51 | 0.0005707 | 0.006018 |
88 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 96 | 588 | 0.0005627 | 0.006018 |
89 | DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 12 | 36 | 0.0005765 | 0.006018 |
90 | ADENYL NUCLEOTIDE BINDING | 219 | 1514 | 0.0006094 | 0.00629 |
91 | PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 19 | 73 | 0.0006228 | 0.006358 |
92 | POTASSIUM CHANNEL ACTIVITY | 27 | 120 | 0.0006552 | 0.006616 |
93 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 16 | 57 | 0.0006712 | 0.006705 |
94 | PROTEIN COMPLEX SCAFFOLD | 18 | 68 | 0.0006899 | 0.006818 |
95 | ACTIN FILAMENT BINDING | 27 | 121 | 0.0007503 | 0.007338 |
96 | X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 7 | 15 | 0.0008532 | 0.007926 |
97 | NITRIC OXIDE SYNTHASE BINDING | 8 | 19 | 0.0008374 | 0.007926 |
98 | ICOSANOID RECEPTOR ACTIVITY | 7 | 15 | 0.0008532 | 0.007926 |
99 | CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 28 | 128 | 0.0008427 | 0.007926 |
100 | PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 7 | 15 | 0.0008532 | 0.007926 |
101 | HISTONE ACETYLTRANSFERASE BINDING | 10 | 28 | 0.0008941 | 0.008224 |
102 | PROTEIN DIMERIZATION ACTIVITY | 170 | 1149 | 0.0009094 | 0.008282 |
103 | HISTONE DEACETYLASE BINDING | 24 | 105 | 0.001007 | 0.009084 |
104 | PHOSPHATIDYLINOSITOL BINDING | 39 | 200 | 0.001046 | 0.009344 |
105 | SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 136 | 0.001056 | 0.009344 |
106 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 34 | 168 | 0.001096 | 0.009605 |
107 | COLLAGEN BINDING | 17 | 65 | 0.001113 | 0.00966 |
108 | CHROMATIN BINDING | 73 | 435 | 0.001155 | 0.009935 |
109 | TRANSCRIPTION COREPRESSOR ACTIVITY | 42 | 221 | 0.001172 | 0.009986 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | SYNAPSE | 230 | 754 | 5.932e-45 | 3.464e-42 |
2 | NEURON PART | 317 | 1265 | 5.516e-42 | 1.611e-39 |
3 | NEURON PROJECTION | 251 | 942 | 8.854e-38 | 1.724e-35 |
4 | CELL PROJECTION | 378 | 1786 | 1.068e-32 | 1.559e-30 |
5 | SYNAPSE PART | 176 | 610 | 4.547e-31 | 5.311e-29 |
6 | SOMATODENDRITIC COMPARTMENT | 174 | 650 | 1.653e-26 | 1.609e-24 |
7 | CELL JUNCTION | 255 | 1151 | 8.044e-25 | 6.711e-23 |
8 | DENDRITE | 132 | 451 | 3.841e-24 | 2.804e-22 |
9 | MEMBRANE REGION | 245 | 1134 | 2.823e-22 | 1.832e-20 |
10 | POSTSYNAPSE | 114 | 378 | 3.67e-22 | 2.144e-20 |
11 | PLASMA MEMBRANE REGION | 202 | 929 | 8.752e-19 | 4.646e-17 |
12 | CELL BODY | 122 | 494 | 6.102e-16 | 2.97e-14 |
13 | EXCITATORY SYNAPSE | 66 | 197 | 7.214e-16 | 3.241e-14 |
14 | AXON | 107 | 418 | 2.953e-15 | 1.232e-13 |
15 | CELL PROJECTION PART | 193 | 946 | 5.211e-15 | 2.029e-13 |
16 | SYNAPTIC MEMBRANE | 75 | 261 | 8.215e-14 | 2.999e-12 |
17 | PRESYNAPSE | 77 | 283 | 8.598e-13 | 2.954e-11 |
18 | CELL LEADING EDGE | 86 | 350 | 1.68e-11 | 5.449e-10 |
19 | CATION CHANNEL COMPLEX | 51 | 167 | 6.806e-11 | 2.092e-09 |
20 | EXTRACELLULAR MATRIX | 96 | 426 | 2.029e-10 | 5.924e-09 |
21 | PROTEINACEOUS EXTRACELLULAR MATRIX | 84 | 356 | 2.569e-10 | 7.144e-09 |
22 | POSTSYNAPTIC MEMBRANE | 57 | 205 | 3.145e-10 | 8.35e-09 |
23 | MEMBRANE MICRODOMAIN | 71 | 288 | 8.327e-10 | 2.114e-08 |
24 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 271 | 1649 | 3.193e-09 | 7.769e-08 |
25 | CELL SURFACE | 143 | 757 | 5.162e-09 | 1.206e-07 |
26 | PLASMA MEMBRANE PROTEIN COMPLEX | 105 | 510 | 6.141e-09 | 1.379e-07 |
27 | AXON PART | 56 | 219 | 1.249e-08 | 2.702e-07 |
28 | SARCOLEMMA | 38 | 125 | 2.02e-08 | 4.213e-07 |
29 | NEURON SPINE | 37 | 121 | 2.599e-08 | 5.233e-07 |
30 | TRANSPORTER COMPLEX | 72 | 321 | 4.486e-08 | 8.732e-07 |
31 | CONTRACTILE FIBER | 53 | 211 | 5.762e-08 | 1.085e-06 |
32 | NEURONAL POSTSYNAPTIC DENSITY | 21 | 53 | 2.143e-07 | 3.793e-06 |
33 | EXTRACELLULAR MATRIX COMPONENT | 36 | 125 | 2.141e-07 | 3.793e-06 |
34 | I BAND | 35 | 121 | 2.796e-07 | 4.802e-06 |
35 | LAMELLIPODIUM | 44 | 172 | 4.326e-07 | 7.219e-06 |
36 | SITE OF POLARIZED GROWTH | 39 | 149 | 1.031e-06 | 1.672e-05 |
37 | PLASMA MEMBRANE RAFT | 27 | 86 | 1.08e-06 | 1.704e-05 |
38 | ACTIN CYTOSKELETON | 87 | 444 | 1.12e-06 | 1.721e-05 |
39 | ANCHORING JUNCTION | 93 | 489 | 1.86e-06 | 2.785e-05 |
40 | POTASSIUM CHANNEL COMPLEX | 27 | 90 | 2.888e-06 | 4.216e-05 |
41 | CELL CELL JUNCTION | 75 | 383 | 6.158e-06 | 8.772e-05 |
42 | T TUBULE | 17 | 45 | 6.579e-06 | 9.147e-05 |
43 | NEURON PROJECTION TERMINUS | 33 | 129 | 1.145e-05 | 0.0001555 |
44 | PERIKARYON | 29 | 108 | 1.412e-05 | 0.0001874 |
45 | BASEMENT MEMBRANE | 26 | 93 | 1.786e-05 | 0.0002318 |
46 | FILOPODIUM | 26 | 94 | 2.195e-05 | 0.0002786 |
47 | EXOCYTIC VESICLE | 34 | 142 | 3.791e-05 | 0.0004711 |
48 | GOLGI APPARATUS | 217 | 1445 | 7.538e-05 | 0.0009171 |
49 | CYTOSKELETON | 285 | 1967 | 7.942e-05 | 0.0009277 |
50 | CELL SUBSTRATE JUNCTION | 73 | 398 | 7.821e-05 | 0.0009277 |
51 | CELL CELL CONTACT ZONE | 19 | 64 | 9.657e-05 | 0.001087 |
52 | CYTOPLASMIC REGION | 56 | 287 | 9.701e-05 | 0.001087 |
53 | RECEPTOR COMPLEX | 62 | 327 | 0.0001005 | 0.001087 |
54 | NEUROMUSCULAR JUNCTION | 17 | 54 | 9.938e-05 | 0.001087 |
55 | VESICLE MEMBRANE | 89 | 512 | 0.0001047 | 0.001112 |
56 | MYELIN SHEATH | 37 | 168 | 0.0001182 | 0.001233 |
57 | PRESYNAPTIC MEMBRANE | 17 | 55 | 0.0001282 | 0.001313 |
58 | CYTOPLASMIC VESICLE PART | 101 | 601 | 0.0001407 | 0.001417 |
59 | LEADING EDGE MEMBRANE | 31 | 134 | 0.0001606 | 0.00159 |
60 | CALCIUM CHANNEL COMPLEX | 18 | 62 | 0.0001999 | 0.001946 |
61 | BASOLATERAL PLASMA MEMBRANE | 43 | 211 | 0.0002245 | 0.002121 |
62 | INTRACELLULAR VESICLE | 189 | 1259 | 0.0002251 | 0.002121 |
63 | CELL CORTEX | 47 | 238 | 0.0002543 | 0.002357 |
64 | PRESYNAPTIC ACTIVE ZONE | 11 | 29 | 0.0002714 | 0.002476 |
65 | DENSE CORE GRANULE | 7 | 13 | 0.0002819 | 0.002533 |
66 | PERINUCLEAR REGION OF CYTOPLASM | 104 | 642 | 0.0004509 | 0.00399 |
67 | CELL PROJECTION MEMBRANE | 55 | 298 | 0.0004805 | 0.004188 |
68 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 7 | 14 | 0.0005065 | 0.00435 |
69 | INTERCALATED DISC | 15 | 51 | 0.0005707 | 0.00463 |
70 | COATED PIT | 18 | 67 | 0.0005691 | 0.00463 |
71 | CELL CORTEX PART | 27 | 119 | 0.0005708 | 0.00463 |
72 | BASAL PART OF CELL | 15 | 51 | 0.0005707 | 0.00463 |
73 | SECRETORY VESICLE | 78 | 461 | 0.0006266 | 0.004945 |
74 | ACTOMYOSIN | 17 | 62 | 0.0006213 | 0.004945 |
75 | TERMINAL BOUTON | 17 | 64 | 0.0009213 | 0.007174 |
76 | AXONAL GROWTH CONE | 8 | 20 | 0.001252 | 0.009623 |
77 | A BAND | 11 | 34 | 0.001284 | 0.009741 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | cGMP_PKG_signaling_pathway_hsa04022 | 52 | 163 | 7.07e-12 | 3.676e-10 | |
2 | Rap1_signaling_pathway_hsa04015 | 58 | 206 | 1.288e-10 | 3.348e-09 | |
3 | MAPK_signaling_pathway_hsa04010 | 73 | 295 | 4.03e-10 | 6.985e-09 | |
4 | Focal_adhesion_hsa04510 | 55 | 199 | 8.163e-10 | 1.061e-08 | |
5 | Regulation_of_actin_cytoskeleton_hsa04810 | 56 | 208 | 1.663e-09 | 1.716e-08 | |
6 | Calcium_signaling_pathway_hsa04020 | 51 | 182 | 1.98e-09 | 1.716e-08 | |
7 | cAMP_signaling_pathway_hsa04024 | 52 | 198 | 1.566e-08 | 1.163e-07 | |
8 | Apelin_signaling_pathway_hsa04371 | 40 | 137 | 3.051e-08 | 1.983e-07 | |
9 | ErbB_signaling_pathway_hsa04012 | 27 | 85 | 8.337e-07 | 4.817e-06 | |
10 | Hippo_signaling_pathway_hsa04390 | 39 | 154 | 2.502e-06 | 1.301e-05 | |
11 | PI3K_Akt_signaling_pathway_hsa04151 | 71 | 352 | 3.698e-06 | 1.748e-05 | |
12 | Phospholipase_D_signaling_pathway_hsa04072 | 37 | 146 | 4.399e-06 | 1.906e-05 | |
13 | Gap_junction_hsa04540 | 26 | 88 | 5.979e-06 | 2.392e-05 | |
14 | Ras_signaling_pathway_hsa04014 | 51 | 232 | 7.231e-06 | 2.686e-05 | |
15 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 35 | 139 | 9.187e-06 | 3.185e-05 | |
16 | FoxO_signaling_pathway_hsa04068 | 32 | 132 | 4.888e-05 | 0.0001589 | |
17 | Wnt_signaling_pathway_hsa04310 | 33 | 146 | 0.0001609 | 0.000492 | |
18 | Hippo_signaling_pathway_multiple_species_hsa04392 | 11 | 29 | 0.0002714 | 0.0007839 | |
19 | Cell_adhesion_molecules_.CAMs._hsa04514 | 32 | 145 | 0.0003172 | 0.0008682 | |
20 | Hedgehog_signaling_pathway_hsa04340 | 14 | 47 | 0.00075 | 0.00195 | |
21 | Phosphatidylinositol_signaling_system_hsa04070 | 23 | 99 | 0.001004 | 0.002486 | |
22 | mTOR_signaling_pathway_hsa04150 | 31 | 151 | 0.001394 | 0.003205 | |
23 | Adherens_junction_hsa04520 | 18 | 72 | 0.001418 | 0.003205 | |
24 | ECM_receptor_interaction_hsa04512 | 19 | 82 | 0.002739 | 0.005935 | |
25 | TGF_beta_signaling_pathway_hsa04350 | 19 | 84 | 0.003651 | 0.007593 | |
26 | Sphingolipid_signaling_pathway_hsa04071 | 24 | 118 | 0.005152 | 0.0103 | |
27 | Autophagy_animal_hsa04140 | 25 | 128 | 0.007465 | 0.01438 | |
28 | VEGF_signaling_pathway_hsa04370 | 13 | 59 | 0.01821 | 0.03382 | |
29 | HIF_1_signaling_pathway_hsa04066 | 19 | 100 | 0.02366 | 0.04243 | |
30 | ABC_transporters_hsa02010 | 10 | 45 | 0.03397 | 0.05888 | |
31 | Tight_junction_hsa04530 | 28 | 170 | 0.04209 | 0.0706 | |
32 | AMPK_signaling_pathway_hsa04152 | 21 | 121 | 0.04436 | 0.07209 | |
33 | Neuroactive_ligand_receptor_interaction_hsa04080 | 42 | 278 | 0.05477 | 0.08481 | |
34 | Oocyte_meiosis_hsa04114 | 21 | 124 | 0.05545 | 0.08481 | |
35 | Jak_STAT_signaling_pathway_hsa04630 | 26 | 162 | 0.06318 | 0.09387 | |
36 | Cellular_senescence_hsa04218 | 25 | 160 | 0.08633 | 0.1247 | |
37 | TNF_signaling_pathway_hsa04668 | 17 | 108 | 0.1313 | 0.1845 | |
38 | Endocytosis_hsa04144 | 32 | 244 | 0.2867 | 0.3923 | |
39 | p53_signaling_pathway_hsa04115 | 9 | 68 | 0.4098 | 0.5464 | |
40 | Mitophagy_animal_hsa04137 | 8 | 65 | 0.5053 | 0.6457 | |
41 | Cytokine_cytokine_receptor_interaction_hsa04060 | 32 | 270 | 0.5158 | 0.6457 | |
42 | Peroxisome_hsa04146 | 10 | 83 | 0.5215 | 0.6457 | |
43 | Notch_signaling_pathway_hsa04330 | 5 | 48 | 0.6826 | 0.8225 | |
44 | NF_kappa_B_signaling_pathway_hsa04064 | 10 | 95 | 0.6959 | 0.8225 | |
45 | Apoptosis_hsa04210 | 14 | 138 | 0.7637 | 0.8635 | |
46 | Apoptosis_multiple_species_hsa04215 | 3 | 33 | 0.7639 | 0.8635 | |
47 | Phagosome_hsa04145 | 15 | 152 | 0.804 | 0.8896 | |
48 | Ferroptosis_hsa04216 | 3 | 40 | 0.866 | 0.9382 | |
49 | Cell_cycle_hsa04110 | 9 | 124 | 0.9638 | 0.9951 | |
50 | Lysosome_hsa04142 | 7 | 123 | 0.9927 | 0.9951 | |
51 | Necroptosis_hsa04217 | 10 | 164 | 0.9951 | 0.9951 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | MIR143HG |
hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -0.739 | 0.0574 | -0.459 | 0.04475 | 0.818 |
2 | USP3-AS1 |
hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -0.162 | 0.47687 | -0.459 | 0.04475 | 0.775 |
3 | SNHG14 |
hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -1.111 | 0.0003 | -0.459 | 0.04475 | 0.7 |
4 | MAGI2-AS3 |
hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -0.129 | 0.57177 | -0.459 | 0.04475 | 0.696 |
5 | RP11-166D19.1 | hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -0.576 | 0.10121 | -0.459 | 0.04475 | 0.68 |
6 | MIR143HG |
hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -0.739 | 0.0574 | -2.039 | 1.0E-5 | 0.647 |
7 | FENDRR |
hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -1.281 | 0.00012 | -0.459 | 0.04475 | 0.644 |
8 | ZNF667-AS1 |
hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -0.976 | 0.00025 | -0.459 | 0.04475 | 0.62 |
9 | SNHG14 |
hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -1.111 | 0.0003 | -2.039 | 1.0E-5 | 0.603 |
10 | USP3-AS1 |
hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -0.162 | 0.47687 | -2.039 | 1.0E-5 | 0.595 |
11 | ARHGEF26-AS1 |
hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -2.46 | 0 | -0.459 | 0.04475 | 0.585 |
12 | ARHGEF26-AS1 |
hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -2.46 | 0 | -2.039 | 1.0E-5 | 0.583 |
13 | FENDRR |
hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -1.281 | 0.00012 | -2.039 | 1.0E-5 | 0.581 |
14 | ZNF667-AS1 |
hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -0.976 | 0.00025 | -2.039 | 1.0E-5 | 0.559 |
15 | MAGI2-AS3 |
hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -0.129 | 0.57177 | -2.039 | 1.0E-5 | 0.556 |
16 | LINC00476 | hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -0.615 | 0.00015 | -2.039 | 1.0E-5 | 0.471 |
17 | PART1 | hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -2.925 | 0 | -0.459 | 0.04475 | 0.413 |
18 | TPTEP1 |
hsa-miR-146b-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-935 | 10 | LPP | Sponge network | -1.216 | 0 | -0.459 | 0.04475 | 0.406 |
19 | TPTEP1 |
hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -1.216 | 0 | -2.039 | 1.0E-5 | 0.382 |
20 | FZD10-AS1 | hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -0.727 | 0.04726 | -2.039 | 1.0E-5 | 0.332 |
21 | SOX2-OT |
hsa-miR-135b-5p;hsa-miR-141-5p;hsa-miR-146b-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200a-5p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-92a-1-5p;hsa-miR-935 | 10 | LONRF2 | Sponge network | -1.264 | 6.0E-5 | -2.039 | 1.0E-5 | 0.262 |